Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	TRIO SIPA1L3 OBSCN ARHGAP30 ARHGEF11 ARHGEF17 FAM13B RHOU HERC2 ARHGEF6 RASAL1 DOCK2 WASL TBC1D30 RAPGEF1 ARHGAP9 NPRL2 ARHGEF40 LLGL1 KNDC1 WDR41	1.62e-05	507	288	21	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	TRIO SIPA1L3 OBSCN ARHGAP30 ARHGEF11 ARHGEF17 FAM13B RHOU HERC2 ARHGEF6 RASAL1 DOCK2 WASL TBC1D30 RAPGEF1 ARHGAP9 NPRL2 ARHGEF40 LLGL1 KNDC1 WDR41	1.62e-05	507	288	21	GO:0030695
GeneOntologyMolecularFunction	complement receptor activity	GPR32 GPR32P1 CR1 CR2	3.79e-05	14	288	4	GO:0004875
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	TRIO OBSCN ARHGEF11 ARHGEF17 RHOU HERC2 ARHGEF6 DOCK2 RAPGEF1 ARHGEF40 KNDC1 WDR41	1.41e-04	231	288	12	GO:0005085
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	TRIO SIPA1L3 OBSCN ARHGAP30 ARHGEF11 ARHGEF17 FAM13B RHOU NOTCH2 RASAL1 DOCK2 SEMA4D GPR35 RAPGEF1 ARHGAP9 ARHGEF40 IGF1 LRP4	1.40e-06	333	292	18	GO:0051056
HumanPheno	Small pituitary gland	GHSR HS6ST1 MED12 MAGEL2 MAST3	6.41e-06	14	107	5	HP:0012506
Domain	EGF_2	SSPOP LTBP4 NOTCH2 HSPG2 STAB2 ZAN TENM4 CELSR3 PRF1 SCUBE3 LRP4 LTBP2 TNXB EPHA10 SORL1	1.54e-05	265	286	15	PS01186
Domain	EGF_3	SSPOP LTBP4 NOTCH2 HSPG2 STAB2 ZAN TENM4 CELSR3 PRF1 SCUBE3 LRP4 LTBP2 TNXB SORL1	1.67e-05	235	286	14	PS50026
Domain	TSP_1	THSD1 SSPOP ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8 CCN1	4.88e-05	63	286	7	PF00090
Domain	EGF-like_CS	LTBP4 NOTCH2 HSPG2 STAB2 ZAN TENM4 CELSR3 PRF1 SCUBE3 LRP4 LTBP2 TNXB EPHA10 SORL1	5.32e-05	261	286	14	IPR013032
Domain	TSP1_rpt	THSD1 SSPOP ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8 CCN1	5.98e-05	65	286	7	IPR000884
Domain	TSP1	THSD1 SSPOP ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8 CCN1	5.98e-05	65	286	7	PS50092
Domain	TSP1	THSD1 SSPOP ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8 CCN1	5.98e-05	65	286	7	SM00209
Domain	-	A1BG TRIO PSG2 OBSCN MCAM PTGFRN LY6G6F PTPRM IGSF3 PAPPA2 SEMA4D HSPG2 COL6A3 FLNC MID2 COL20A1 ICAM3 PLXNC1 CD33 LINGO4 TNXB EPHA10 LRIT1 SORL1	9.16e-05	663	286	24	2.60.40.10
Domain	APC_su10/DOC_dom	CUL9 HERC2 HECTD3	1.19e-04	7	286	3	IPR004939
Domain	ANAPC10	CUL9 HERC2 HECTD3	1.19e-04	7	286	3	PF03256
Domain	APC10	CUL9 HERC2 HECTD3	1.19e-04	7	286	3	SM01337
Domain	DOC	CUL9 HERC2 HECTD3	1.19e-04	7	286	3	PS51284
Domain	EGF-like_dom	LTBP4 NOTCH2 HSPG2 STAB2 ZAN TENM4 CELSR3 PRF1 SCUBE3 LRP4 LTBP2 TNXB SORL1	1.29e-04	249	286	13	IPR000742
Domain	FN3	OBSCN PTPRM PAPPA2 COL6A3 FLNC MID2 COL20A1 TNXB EPHA10 LRIT1 SORL1	1.37e-04	185	286	11	SM00060
Domain	ZF_ZZ_2	HERC2 DYTN MIB2 EP300	1.39e-04	18	286	4	PS50135
Domain	ZF_ZZ_1	HERC2 DYTN MIB2 EP300	1.39e-04	18	286	4	PS01357
Domain	ZZ	HERC2 DYTN MIB2 EP300	1.39e-04	18	286	4	PF00569
Domain	EGF	NOTCH2 HSPG2 STAB2 ZAN CELSR3 SCUBE3 LRP4 LTBP2 TNXB	1.41e-04	126	286	9	PF00008
Domain	EGF_1	SSPOP LTBP4 NOTCH2 HSPG2 STAB2 ZAN TENM4 CELSR3 PRF1 SCUBE3 LRP4 LTBP2 TNXB	1.63e-04	255	286	13	PS00022
Domain	ig	A1BG PSG2 OBSCN MCAM PTGFRN PTPRM SEMA4D HSPG2 ICAM3 CD33 LRIT1	1.73e-04	190	286	11	PF00047
Domain	Immunoglobulin	A1BG PSG2 OBSCN MCAM PTGFRN PTPRM SEMA4D HSPG2 ICAM3 CD33 LRIT1	1.73e-04	190	286	11	IPR013151
Domain	Znf_ZZ	HERC2 DYTN MIB2 EP300	1.74e-04	19	286	4	IPR000433
Domain	ZnF_ZZ	HERC2 DYTN MIB2 EP300	1.74e-04	19	286	4	SM00291
Domain	Ig-like_fold	A1BG TRIO PSG2 OBSCN MCAM PTGFRN LY6G6F PTPRM IGSF3 PAPPA2 SEMA4D HSPG2 COL6A3 FLNC MID2 COL20A1 ICAM3 PLXNC1 CD33 LINGO4 TNXB EPHA10 LRIT1 SORL1	2.35e-04	706	286	24	IPR013783
Domain	ARM-like	APC2 CUL9 RIPOR3 MROH7 GCN1 TARBP1 MED12 TNPO1 DOCK2 COPG1 CLASP1 PKP4 CTNND2	2.84e-04	270	286	13	IPR011989
Domain	EGF	LTBP4 NOTCH2 HSPG2 STAB2 ZAN TENM4 CELSR3 SCUBE3 LRP4 LTBP2 TNXB SORL1	2.85e-04	235	286	12	SM00181
Domain	ADAM_spacer1	ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8	3.79e-04	23	286	4	IPR010294
Domain	ADAM_spacer1	ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8	3.79e-04	23	286	4	PF05986
Domain	FN3_dom	OBSCN PTPRM PAPPA2 COL6A3 FLNC MID2 COL20A1 TNXB EPHA10 LRIT1 SORL1	3.93e-04	209	286	11	IPR003961
Domain	DH_1	TRIO OBSCN ARHGEF11 ARHGEF17 ARHGEF6 ARHGEF40	4.00e-04	63	286	6	PS00741
Domain	ConA-like_dom	MEFV PTPRM COL21A1 PAPPA2 HSPG2 ZAN MID2 COL20A1 RFPL4AL1 RFPL4A CELSR3	5.82e-04	219	286	11	IPR013320
Domain	EGF_CA	LTBP4 NOTCH2 HSPG2 STAB2 CELSR3 SCUBE3 LRP4 LTBP2	5.85e-04	122	286	8	SM00179
Domain	-	APC2 CUL9 RIPOR3 MROH7 GCN1 MED12 TNPO1 COPG1 CLASP1 PKP4 CTNND2	6.51e-04	222	286	11	1.25.10.10
Domain	EGF-like_Ca-bd_dom	LTBP4 NOTCH2 HSPG2 STAB2 CELSR3 SCUBE3 LRP4 LTBP2	6.52e-04	124	286	8	IPR001881
Domain	Growth_fac_rcpt_	LTBP4 NOTCH2 HSPG2 STAB2 CCN1 SCUBE3 LRP4 LTBP2 TNXB	6.85e-04	156	286	9	IPR009030
Domain	CPH_domain	CUL9 HERC2	6.94e-04	3	286	2	IPR021097
Domain	Beta-propeller_rpt_TECPR	TECPR2 HERC2	6.94e-04	3	286	2	IPR006624
Domain	Cul7	CUL9 HERC2	6.94e-04	3	286	2	PF11515
Domain	TECPR	TECPR2 HERC2	6.94e-04	3	286	2	SM00706
Domain	RhoGEF	TRIO OBSCN ARHGEF11 ARHGEF17 ARHGEF6 ARHGEF40	7.06e-04	70	286	6	PF00621
Domain	DH_2	TRIO OBSCN ARHGEF11 ARHGEF17 ARHGEF6 ARHGEF40	7.06e-04	70	286	6	PS50010
Domain	ZF_RING_2	CUL9 RNF187 TTC3 RNF115 RNF31 MID2 MIB2 RFPL4AL1 KMT2D RFPL4A NEURL1 RNF41 PDZRN3	7.22e-04	298	286	13	PS50089
Domain	-	TRIO OBSCN ARHGEF11 ARHGEF17 ARHGEF6 ARHGEF40	7.61e-04	71	286	6	1.20.900.10
Domain	DH-domain	TRIO OBSCN ARHGEF11 ARHGEF17 ARHGEF6 ARHGEF40	7.61e-04	71	286	6	IPR000219
Domain	LDLRA_1	SSPOP PKD1 HSPG2 LRP4 SORL1	8.12e-04	48	286	5	PS01209
Domain	IG	A1BG TRIO PSG2 OBSCN MCAM PTGFRN LY6G6F PTPRM IGSF3 SEMA4D HSPG2 ICAM3 MPIG6B CD33 LINGO4 LRIT1	8.20e-04	421	286	16	SM00409
Domain	Ig_sub	A1BG TRIO PSG2 OBSCN MCAM PTGFRN LY6G6F PTPRM IGSF3 SEMA4D HSPG2 ICAM3 MPIG6B CD33 LINGO4 LRIT1	8.20e-04	421	286	16	IPR003599
Domain	LDLRA_2	SSPOP PKD1 HSPG2 LRP4 SORL1	8.94e-04	49	286	5	PS50068
Domain	NGF	BDNF NTF4	1.37e-03	4	286	2	PF00243
Domain	MIB_HERC2	HERC2 MIB2	1.37e-03	4	286	2	PS51416
Domain	MIB_HERC2	HERC2 MIB2	1.37e-03	4	286	2	PF06701
Domain	NGF_1	BDNF NTF4	1.37e-03	4	286	2	PS00248
Domain	NGF	BDNF NTF4	1.37e-03	4	286	2	SM00140
Domain	Nerve_growth_factor-rel	BDNF NTF4	1.37e-03	4	286	2	PD002052
Domain	Mib_Herc2	HERC2 MIB2	1.37e-03	4	286	2	IPR010606
Domain	Nerve_growth_factor-like	BDNF NTF4	1.37e-03	4	286	2	IPR020408
Domain	Nerve_growth_factor_CS	BDNF NTF4	1.37e-03	4	286	2	IPR019846
Domain	NGF_2	BDNF NTF4	1.37e-03	4	286	2	PS50270
Domain	Nerve_growth_factor-rel	BDNF NTF4	1.37e-03	4	286	2	IPR002072
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD1 SSPOP ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8	2.14e-05	39	209	6	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD1 SSPOP ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8	2.14e-05	39	209	6	MM15165
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	THSD1 SSPOP ADAMTS9 ADAMTSL4 NOTCH2 ADAMTS1 ADAMTS8	6.42e-05	68	209	7	M27303
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRIO VWA8 SIPA1L3 INTS1 OBSCN CUL9 EDC4 SRCAP ARHGEF11 TTC3 DCTN1 JAK3 LIME1 FASN ZC3H11A PKD1 LRRC56 KIFC3 HERC2 LTBP4 GCN1 MED12 NOTCH2 RASAL1 ZNF687 IGSF3 BAHCC1 HSPG2 FLNC RAPGEF1 ICE1 MIB2 ARHGEF40 KMT2D IGF2R CELSR3 RPAP1 MTMR14 BTBD7 LRP4 SLC45A1 ZNF839 EP300	2.35e-16	1105	303	43	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SP100 VWA8 TPRN BACH2 CUL9 SRCAP TRIP13 ZC3H3 ZKSCAN5 DNASE2B LTBP4 NOTCH2 ZNF687 BAHCC1 TDRKH RNF31 ADAMTS1 RNASEH2A HECTD3 POLD1 PKP4 BTBD18 HAUS5 RSBN1 ARHGEF40 NEURL1 LRP4 RERE USP54 CSMD1 KIF18B PDZRN3 EP300 SORL1	3.01e-10	1116	303	34	31753913
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HEXB TRIO SIPA1L3 APC2 DDIT4L CUL9 PSMD4 TTC3 DCTN1 ZKSCAN5 ADAMTS9 PKD1 NAV3 STAMBPL1 KIFC3 HERC2 TARBP1 SEMA4D WASL ANK3 ADAMTS1 PLA2G3 NFKBID ADAMTS8 IDS NPRL2 CELSR3 CCN1 LRP4 PAX6 USP54 CTNND2 TNKS2 SLX4 EP300	3.01e-09	1285	303	35	35914814
Pubmed	A human MAP kinase interactome.	SP100 EXPH5 PSMD4 NEB ARHGEF11 DCTN1 FAM13B LENG8 NAV3 HERC2 GCN1 FLNC WASL TCF20 ANK3 RAPGEF1 ZNF106 IRAG2 ZNF839 EP300	1.33e-08	486	303	20	20936779
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	INTS1 PTGFRN ADAMTS9 STARD9 PDP2 STAMBPL1 CARNS1 ZNF687 ADAMTS1 TENM4 RPAP1	1.14e-07	153	303	11	10718198
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	VWA8 CUL9 ARHGEF11 SSPOP CARNS1 BAHCC1 FEM1B CELSR3 LRP4 MAST3	2.30e-07	130	303	10	12421765
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	PSMD4 SPATA2 FASN PDP2 HERC2 GCN1 TNPO1 CAD RNF31 COPG1 RNF41	6.54e-07	182	303	11	31067453
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CUL9 SMC5 SPATA2 ARHGEF17 ZC3H11A STARD9 NAV3 TCF20 CLASP1 ZSWIM5 FEM1B RSBN1 TENM4 RPAP1 BTBD7 RERE	7.05e-07	407	303	16	12693553
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	EPX PRMT5 PKD1 KIFC3 IGSF3 DNHD1 EEFSEC COL6A3 CLASP1 CELSR3 IRAG2	8.55e-07	187	303	11	26460568
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	SSPOP ADAMTS9 HSPG2 COL6A3 COL20A1 ADAMTS8 TNXB	1.44e-06	64	303	7	22261194
Pubmed	The DNA sequence and biological annotation of human chromosome 1.	OBSCN PSMD4 ARHGAP30 RNF187 ARHGEF11 RNF115 TEKT2 KCNJ9 ADAMTSL4 TARBP1 ZNF687 PAPPA2 ANKRD35 SPATA6 HECTD3 ZSWIM5 GJC2 HES3 PRDX6 OPRD1 GREM2 MTF1 RERE SLC45A1 ZP4 MUTYH	1.52e-06	1031	303	26	16710414
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	VWA8 EDC4 DCTN1 FASN NUP210 GCN1 WASL CAD SMCHD1 ARHGEF40 USP54	1.82e-06	202	303	11	24639526
Pubmed	Functional proteomics mapping of a human signaling pathway.	PSG2 EXPH5 TPRN MCAM TTC3 DCTN1 PKD1 HERC2 NOTCH2 PAPPA2 HSPG2 FLNC ANK3 ARHGAP9 E4F1 ZNF106 KMT2D TNKS2	5.34e-06	591	303	18	15231748
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	INTS1 CUL9 EDC4 FASN ZC3H11A GLYR1 PRMT5 NUP210 HERC2 GCN1 MED12 TNPO1 FLNC CAD TCF20 COPG1 SMCHD1 IGF2R GTF3C1	5.62e-06	653	303	19	22586326
Pubmed	A gene-targeting approach for functional characterization of KIAA genes encoding extremely large proteins.	INTS1 BAHCC1 KNDC1	6.46e-06	5	303	3	16807365
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	CUL9 EPX ARHGEF11 PKD1 TNPO1 CCR10 FLNC WASL POLD1 RAPGEF1 CELSR3 LTBP2 GRIP2	7.41e-06	329	303	13	17474147
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EDC4 SRCAP DCTN1 FASN ZC3H11A GCN1 MED12 CAD TCF20 ANK3 SMCHD1 HAUS5 PRDX6 KMT2D GTF3C1 TET1 EP300	7.88e-06	549	303	17	38280479
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	CTTNBP2 TRIO OBSCN NEB TTC3 DCTN1 ADAMTS9 SLMAP NOTCH2 HSPG2 COL6A3 FLNC WASL ZFAT MTMR14 TNKS2	9.03e-06	497	303	16	23414517
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	ADAMTSL4 HSPG2 COL6A3 ADAMTS1 CCN1 LTBP2 TNXB	1.06e-05	86	303	7	28327460
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	INTS1 EDC4 SRCAP BDH1 LENG8 NUP210 MED12 ZNF687 TCF20 SMCHD1 RSBN1 KMT2D GTF3C1	1.09e-05	341	303	13	32971831
Pubmed	Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones.	IRF9 DNHD1 RNF31 ARHGEF40	1.23e-05	17	303	4	12693554
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	TRIO FASN NUP210 MROH7 HERC2 GCN1 CAD SMCHD1 ICE1 ARHGEF40	1.24e-05	202	303	10	33005030
Pubmed	Differential induction of Pax genes by NGF and BDNF in cerebellar primary cultures.	BDNF NTF4 PAX6	1.28e-05	6	303	3	8163557
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	A1BG TRIO PSG2 OBSCN MCAM PTGFRN PTPRM IGSF3 LRIT1	1.35e-05	162	303	9	25826454
Pubmed	Common genetic variation and performance on standardized cognitive tests.	BACH2 BDNF TBC1D30 GRIK4 IDS CSMD1	1.70e-05	62	303	6	20125193
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	SYT17 THSD1 BDNF PKD1 COL4A6 ADAMTS1 ADAMTS8 PAX6 ATOH1 TNXB	1.74e-05	210	303	10	16537572
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	CTTNBP2 TRIO SIPA1L3 CUL9 SLMAP HERC2 PIPSL HECTD3 POLD1 HAUS5	1.88e-05	212	303	10	33853758
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRIO SIPA1L3 NAIP OBSCN TTC3 TRIP13 SSPOP BDH1 SHKBP1 ZC3H11A TECPR2 GLYR1 NUP210 NOTCH2 SEMA4D SPATA6 ANK3 MID2 ATG7 PPFIBP2 WDR27 PRDX6 IGF1 GTF3C1 KNDC1 OLFM2 RERE CSMD1 ZNF839 EP300	2.01e-05	1489	303	30	28611215
Pubmed	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	ANK3 TENM4 NEURL1 RERE SLC45A1 CSMD1	2.23e-05	65	303	6	23453885
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	HEXB PSMD4 TRIP13 PTGFRN FASN PRMT5 NUP210 LTBP4 GCN1 ADAMTSL4 IGSF3 HSPG2 CAD SMCHD1 IGF2R PRF1 SORL1	3.20e-05	613	303	17	22268729
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CTTNBP2 EXPH5 SIPA1L3 PTGFRN ZKSCAN5 ADAMTS9 NUP210 MED12 DOCK2 TBC1D30 PRDX6 FHDC1 PDZRN3 SLX4 MAST3	3.29e-05	493	303	15	15368895
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	VWA8 DACT2 EDC4 DCTN1 FASN GLYR1 NUP210 ZNF687 MPO CAD COPG1 SMCHD1 DNAH2 HES3 ZBTB45 IRAG2 DCHS1 GRIP2 EP300	4.07e-05	754	303	19	35906200
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CTTNBP2 TRIO SIPA1L3 APC2 EDC4 ARHGEF11 TTC3 DCTN1 TMEM132B HERC2 RASAL1 AMPD2 CAD TCF20 ANK3 CLASP1 PKP4 NOSIP IGF2R DCHS1 FRMPD3 CTNND2	4.41e-05	963	303	22	28671696
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	INTS1 PSMD4 HMGCS1 EDC4 RNF187 SMC5 TRIP13 DCTN1 PGGT1B TBCB LENG8 FASN ZC3H11A GCN1 MED12 TNPO1 CAD ZFAT GJC2 NOSIP ZNF106 NPRL2 MTF1 BTBD7 RERE BBC3 EP300	4.49e-05	1327	303	27	32694731
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	SSPOP ADAMTS9 ADAMTSL4 ADAMTS1 ADAMTS8 CCN1	5.06e-05	75	303	6	20637190
Pubmed	TCF20 dysfunction leads to cortical neurogenesis defects and autistic-like behaviors in mice.	SATB2 TCF20 PAX6	5.29e-05	9	303	3	32510763
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	INTS1 PSMD4 LENG8 MED12 TCF20 RNASEH2A POLD1 HAUS5 NCOA4 ZNF106	5.79e-05	242	303	10	34011540
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	ADAMDEC1 COL21A1 LTBP4 ADAMTSL4 COL4A6 HSPG2 COL6A3 TNXB	6.28e-05	153	303	8	25037231
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	MIS18BP1 TRIO BACH2 SIPA1L3 SPATA2 ARHGEF11 DCTN1 TBCB LENG8 PRMT5 HERC2 PLEKHA7 LTBP4 WASL PKP4 HAUS5 IGF2R MTMR14 USP54 PDZRN3	6.91e-05	853	303	20	28718761
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	SIPA1L3 PTGFRN PGGT1B BNIP1 PTPRM HERC2 PLEKHA7 TARBP1 NOTCH2 IGSF3 WASL PPFIBP2 PKP4 NCOA4 FEM1B IGF2R LLGL1 LRP4	7.04e-05	719	303	18	35337019
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SP100 SIPA1L3 DACT2 SRCAP NEB EPX TTC3 TRIP13 DCTN1 GRPEL2 TBCB FASN BNIP1 STARD9 BAHCC1 FLNC COL20A1 ZSWIM5 SMCHD1 DNAH2 CTAGE6 TEX14 MINDY2 SH3D21 GTF3C1 CTAGE15 PCDHGC3 CFAP46	7.23e-05	1442	303	28	35575683
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	VWA8 TECPR2 SLMAP CARNS1 ZNF687 IGSF3 SATB2 PDPR SMCHD1 HAUS5 ICE1 CELSR3 TET1 LRP4 FAM53B	7.28e-05	529	303	15	14621295
Pubmed	Neurotrophin-4/5 is required for the early growth of regenerating axons in peripheral nerves.	BDNF NTF4	7.57e-05	2	303	2	15926911
Pubmed	Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family.	PAPPA2 IGF1	7.57e-05	2	303	2	34272725
Pubmed	Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.	CR1 CR2	7.57e-05	2	303	2	14635039
Pubmed	Uncovering a new role for peroxidase enzymes as drivers of angiogenesis.	EPX MPO	7.57e-05	2	303	2	26386352
Pubmed	Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.	TRIO FLNC	7.57e-05	2	303	2	16914736
Pubmed	p300 promotes differentiation of Th17 cells via positive regulation of the nuclear transcription factor RORγt in acute respiratory distress syndrome.	RORC EP300	7.57e-05	2	303	2	30009847
Pubmed	TET1 Deficiency Impairs Morphogen-free Differentiation of Human Embryonic Stem Cells to Neuroectoderm.	TET1 PAX6	7.57e-05	2	303	2	32587369
Pubmed	ADAMTS1 and HSPG2 mRNA levels in cumulus cells are related to human oocyte quality and controlled ovarian hyperstimulation outcomes.	HSPG2 ADAMTS1	7.57e-05	2	303	2	31974739
Pubmed	Tubulin-binding cofactor B is a direct interaction partner of the dynactin subunit p150(Glued).	DCTN1 TBCB	7.57e-05	2	303	2	22777741
Pubmed	Epithelial overexpression of BDNF or NT4 disrupts targeting of taste neurons that innervate the anterior tongue.	BDNF NTF4	7.57e-05	2	303	2	11401409
Pubmed	BDNF and CGRP interaction: implications in migraine susceptibility.	BDNF CALCA	7.57e-05	2	303	2	20959432
Pubmed	Carboxyl-terminal targeting and novel post-translational processing of JAW1, a lymphoid protein of the endoplasmic reticulum.	FMN1 IRAG2	7.57e-05	2	303	2	8798562
Pubmed	The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.	CR1 CR2	7.57e-05	2	303	2	11981823
Pubmed	Lingual and palatal gustatory afferents each depend on both BDNF and NT-4, but the dependence is greater for lingual than palatal afferents.	BDNF NTF4	7.57e-05	2	303	2	20575060
Pubmed	Identification of rare missense mutations in NOTCH2 and HERC2 associated with familial central precocious puberty via whole-exome sequencing.	HERC2 NOTCH2	7.57e-05	2	303	2	32400230
Pubmed	Differential effects of ergometer-cycling and Whole-Body-Vibration training on serological BDNF and IGF-1 in the treatment of adolescent depression - is there an impact of BDNFp.Val66Met variants?	BDNF IGF1	7.57e-05	2	303	2	34536433
Pubmed	Satb2 neurons in the parabrachial nucleus mediate taste perception.	SATB2 CALCA	7.57e-05	2	303	2	33431851
Pubmed	Gremlin 2 promotes differentiation of embryonic stem cells to atrial fate by activation of the JNK signaling pathway.	CACNA1D GREM2	7.57e-05	2	303	2	24648383
Pubmed	Do BDNF and NT-4/5 exert synergistic or occlusive effects on corticostriatal transmission in a male mouse model of Huntington's disease?	BDNF NTF4	7.57e-05	2	303	2	31392756
Pubmed	Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.	CR1 CR2	7.57e-05	2	303	2	1708808
Pubmed	Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD.	JAK3 PRF1	7.57e-05	2	303	2	25352130
Pubmed	Acute effects of strength and endurance exercise on serum BDNF and IGF-1 levels in older men.	BDNF IGF1	7.57e-05	2	303	2	33441099
Pubmed	Latent TGF-β binding protein 2 and 4 have essential overlapping functions in microfibril development.	LTBP4 LTBP2	7.57e-05	2	303	2	28252045
Pubmed	The Impact of Physical Exercise on the Circulating Levels of BDNF and NT 4/5: A Review.	BDNF NTF4	7.57e-05	2	303	2	34445512
Pubmed	Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.	BDNF NTF4	7.57e-05	2	303	2	21350004
Pubmed	Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.	PKD1 IGF1	7.57e-05	2	303	2	17396115
Pubmed	Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression.	BDNF NTF4	7.57e-05	2	303	2	10616802
Pubmed	Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders.	BDNF IGF1	7.57e-05	2	303	2	29108028
Pubmed	Effects of strength and endurance training on brain-derived neurotrophic factor and insulin-like growth factor 1 in humans.	BDNF IGF1	7.57e-05	2	303	2	18975254
Pubmed	Comparative functional evolution of human and mouse CR1 and CR2.	CR1 CR2	7.57e-05	2	303	2	18713965
Pubmed	P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.	FASN EP300	7.57e-05	2	303	2	26934656
Pubmed	Isoform- and dose-sensitive feedback interactions between paired box 6 gene and delta-catenin in cell differentiation and death.	PAX6 CTNND2	7.57e-05	2	303	2	20074565
Pubmed	Brain-derived neurotrophic factor is required for normal development of the central respiratory rhythm in mice.	BDNF NTF4	7.57e-05	2	303	2	9706001
Pubmed	Effect of Physical Activity on Cognitive Development: Protocol for a 15-Year Longitudinal Follow-Up Study.	BDNF IGF1	7.57e-05	2	303	2	29094050
Pubmed	PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexes.	PRMT5 TDP1	7.57e-05	2	303	2	29718323
Pubmed	BDNF, but not NT-4, is necessary for normal development of Meissner corpuscles.	BDNF NTF4	7.57e-05	2	303	2	15722178
Pubmed	[THE COMBINATION OF EXPRESSION OF MARKERS CR1 AND CR2 (CD35/CD21) IN DIAGNOSTIC OF B-CELL LYMPHOPROLIFERATIVE DISEASES].	CR1 CR2	7.57e-05	2	303	2	26189291
Pubmed	Impact of IGF-I/IGF-IR circuit on the angiogenetic properties of Ewing's sarcoma cells.	IGF1 IGF2R	7.57e-05	2	303	2	14710346
Pubmed	Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency.	PAPPA2 IGF1	7.57e-05	2	303	2	27648969
Pubmed	Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry.	IGF1 IGF2R	7.57e-05	2	303	2	1370435
Pubmed	Disruption of cerebellar granule cell development in the Pax6 mutant, Sey mouse.	PAX6 ATOH1	7.57e-05	2	303	2	16289327
Pubmed	Deleting nebulin's C-terminus reveals its importance to sarcomeric structure and function and is sufficient to invoke nemaline myopathy.	NEB IGF1	7.57e-05	2	303	2	30689900
Pubmed	Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.	RERE SLC45A1	7.57e-05	2	303	2	10729226
Pubmed	Nebulin and N-WASP cooperate to cause IGF-1-induced sarcomeric actin filament formation.	NEB WASL	7.57e-05	2	303	2	21148390
Pubmed	Effect of neurotrophin-4/5 on bone/cementum-related protein expressions and DNA synthesis in cultures of human periodontal ligament cells.	BDNF NTF4	7.57e-05	2	303	2	18980528
Pubmed	Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma.	SEMA4D IGF1	7.57e-05	2	303	2	28656278
Pubmed	Oxygen modulates iron homeostasis by switching iron sensing of NCOA4.	HERC2 NCOA4	7.57e-05	2	303	2	37059186
Pubmed	Impact of exercise training on neuroplasticity-related growth factors in adolescents.	BDNF IGF1	7.57e-05	2	303	2	23989258
Pubmed	Recombinant IGF-1 Induces Sex-Specific Changes in Bone Composition and Remodeling in Adult Mice with Pappa2 Deficiency.	PAPPA2 IGF1	7.57e-05	2	303	2	33919940
Pubmed	Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.	EPX MPO	7.57e-05	2	303	2	28260049
Pubmed	BDNF but not NT-4 is required for normal flexion reflex plasticity and function.	BDNF NTF4	7.57e-05	2	303	2	11438749
Pubmed	Srcap haploinsufficiency induced autistic-like behaviors in mice through disruption of Satb2 expression.	SRCAP SATB2	7.57e-05	2	303	2	38733588
Pubmed	Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.	PAPPA2 IGF1	7.57e-05	2	303	2	26902202
Pubmed	Differential expression and regulation by activin of the neurotrophins BDNF and NT4 during human and mouse ovarian development.	BDNF NTF4	7.57e-05	2	303	2	20175187
Pubmed	METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity.	ADAMTS1 ADAMTS8	7.57e-05	2	303	2	10438512
Pubmed	Study of insulin-like growth factor-1 (IGF-1) and platelet-derived endothelial cell growth factor (PDEGF) expression in children with infantile hypertrophic pyloric stenosis.	TYMP IGF1	7.57e-05	2	303	2	16369467
Pubmed	Epithelial overexpression of BDNF and NT4 produces distinct gustatory axon morphologies that disrupt initial targeting.	BDNF NTF4	7.57e-05	2	303	2	16500639
Pubmed	Role of neurotrophin-4/5 in neural cell death during retinal development and ischemic retinal injury in vivo.	BDNF NTF4	7.57e-05	2	303	2	15671298
Interaction	TOP3B interactions	TRIO VWA8 SIPA1L3 INTS1 OBSCN CUL9 EDC4 SRCAP ARHGEF11 TTC3 DCTN1 JAK3 LIME1 FASN ZC3H11A PRMT5 PKD1 LRRC56 KIFC3 HERC2 LTBP4 GCN1 ADAMTSL4 MED12 NOTCH2 RASAL1 ZNF687 IGSF3 BAHCC1 HSPG2 FLNC TDRKH CAD MID2 RAPGEF1 ICE1 MIB2 ARHGEF40 KMT2D IGF2R CELSR3 RPAP1 MTMR14 BTBD7 LRP4 SLC45A1 ZNF839 EP300	5.93e-08	1470	288	48	int:TOP3B
Interaction	HOOK1 interactions	CWF19L2 SIPA1L3 DCTN1 LENG8 PRMT5 HERC2 PIPSL ANK3 RNF31 HAUS5 SOHLH1 ALOXE3 USP54 PDZRN3	9.91e-06	240	288	14	int:HOOK1
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	HERC2 DYTN MIB2 EP300	4.42e-05	18	206	4	91
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO OBSCN ARHGEF11 ARHGEF17 ARHGEF6 ARHGEF40	1.05e-04	66	206	6	722
GeneFamily	Fibronectin type III domain containing	OBSCN PTPRM MID2 COL20A1 TNXB EPHA10 LRIT1 SORL1	5.04e-04	160	206	8	555
GeneFamily	Latent transforming growth factor beta binding proteins	LTBP4 LTBP2	7.64e-04	4	206	2	628
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	ZBTB48 BACH2 BTBD18 ZBTB45 KLHL5 BTBD7 SLX4	8.72e-04	134	206	7	861
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS9 ADAMTS1 ADAMTS8	1.23e-03	19	206	3	50
GeneFamily	Immunoglobulin like domain containing	A1BG MCAM PTGFRN PTPRM IGSF3 SEMA4D HSPG2 ICAM3	1.70e-03	193	206	8	594
GeneFamily	Collagens	COL21A1 COL4A6 COL6A3 COL20A1	1.84e-03	46	206	4	490
GeneFamily	Ankyrin repeat domain containing	CTTNBP2 TRPV6 NOTCH2 ANKRD35 ANK3 NFKBID MIB2 FEM1B TNKS2	1.87e-03	242	206	9	403
Coexpression	GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP	TRIO SRCAP ARHGEF11 ZKSCAN5 BDH1 IRF9 NUP210 MID2 RDH5 PPEF2 MINDY2 NEURL1	3.25e-06	199	298	12	M8301
Coexpression	GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN	BACH2 ARHGAP30 BDH1 MEFV IRF9 PKD1 STAMBPL1 GPR35 MINDY2 IGF1 FAM53B EP300	3.25e-06	199	298	12	M5726
Coexpression	GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP	CTTNBP2 AGBL5 TTC3 TARBP1 TDRKH AMPD2 POLD1 ARHGAP9 ZNF106 CD33 IRAG2	1.72e-05	197	298	11	M3343
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	INTS1 ARHGEF17 BDH1 NUP210 IGSF3 COL4A6 FLNC CAD NPRL2 IGF2R LRP4 EP300 SORL1	1.85e-05	276	298	13	M3063
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	BACH2 COL21A1 NAV3 CACNA1D COL6A3 ADAMTS1 GRIK4 ADAMTS8 CCN1 LTBP2 TNXB PDZRN3	1.05e-08	195	303	12	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAV3 LTBP4 CACNA1D COL6A3 ADAMTS1 ADAMTS8 ZNF106 CCN1 LTBP2 PCDHGC3 TNXB PDZRN3	1.17e-08	197	303	12	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL21A1 NAV3 CACNA1D COL6A3 ADAMTS1 GRIK4 ADAMTS8 CCN1 LTBP2 TNXB PDZRN3	6.85e-08	187	303	11	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	PTPRM COL21A1 KIFC3 CACNA1D COL6A3 GRIK4 ADAMTS8 ZNF106 CCN1 LTBP2 PDZRN3	8.96e-08	192	303	11	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RHOU PAPPA2 COL4A6 COL6A3 ADAMTS1 GRIK4 ADAMTS8 GREM2 IGF1 CSMD1 PDZRN3	1.05e-07	195	303	11	c6bb16c0076639c6ddef1a15d8cba44bc29c077d
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RHOU PAPPA2 COL4A6 COL6A3 ADAMTS1 GRIK4 ADAMTS8 GREM2 IGF1 CSMD1 PDZRN3	1.05e-07	195	303	11	ea89f80d3d7e9f737442f7c1aa1791d277ffc90c
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NEB PTGFRN COL21A1 LTBP4 IGSF3 FLNC ADAMTS8 CCN1 P2RX6 TET1 OLFM2	1.22e-07	198	303	11	55e583321f60c95898d93cd0d2615c6692db52ec
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BACH2 ARHGAP30 STAP1 JAK3 OR56B1 NUP210 DOCK2 ARHGAP9 CR1 CR2 IRAG2	1.22e-07	198	303	11	824461cf44098440ba8bc0df96735423ac65bda1
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	COL21A1 NAV3 LTBP4 CACNA1D COL6A3 ADAMTS1 ADAMTS8 CCN1 LTBP2 PCDHGC3 TNXB	1.36e-07	200	303	11	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL21A1 NAV3 LTBP4 CACNA1D COL6A3 ADAMTS1 ADAMTS8 CCN1 LTBP2 PCDHGC3 TNXB	1.36e-07	200	303	11	a510deaada669e690329183e18df02870bd204b3
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BACH2 COL21A1 NAV3 CACNA1D COL6A3 ADAMTS1 GRIK4 ADAMTS8 LTBP2 TNXB PDZRN3	1.36e-07	200	303	11	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BACH2 COL21A1 NAV3 CACNA1D COL6A3 GRIK4 ADAMTS8 CCN1 LTBP2 TNXB PDZRN3	1.36e-07	200	303	11	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL21A1 NAV3 LTBP4 CACNA1D COL6A3 ADAMTS1 ADAMTS8 CCN1 LTBP2 PCDHGC3 TNXB	1.36e-07	200	303	11	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FPGT ZC3H3 SHKBP1 SEMA4D SATB2 GPR35 NFKBID IDS HASPIN EP300	3.20e-07	173	303	10	c31076c725f4cd912c56903592a2d9356ae59f54
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FPGT ZC3H3 SHKBP1 SEMA4D SATB2 GPR35 NFKBID IDS HASPIN EP300	3.20e-07	173	303	10	a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACT2 GALNT13 FMN1 PLEKHA7 COL4A6 ANK3 TEX14 TENM4 RORC USP54	4.38e-07	179	303	10	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRIO BACH2 ADAMTS9 ADAMTS1 PKIG IGF1 TENM4 LRP4 LTBP2 PDZRN3	5.10e-07	182	303	10	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN NEB SSPOP GALNT13 NAV3 STAB2 ZAN TENM4 CSMD1 EPHA10	5.64e-07	184	303	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN NEB SSPOP GALNT13 NAV3 STAB2 ZAN TENM4 CSMD1 EPHA10	5.64e-07	184	303	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NEB ARHGEF17 COL6A3 FLNC GJC2 GRIK4 ZNF786 IGF1 CCN1 P2RX6	5.64e-07	184	303	10	e33e2a887aafba7b6a31f00bb0dbe974b4359fd6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN NEB SSPOP GALNT13 NAV3 STAB2 ZAN TENM4 CSMD1 EPHA10	5.64e-07	184	303	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHOU BDNF CYS1 GRIK4 GREM2 IGF1 DCHS1 FRMPD3 CSMD1 PDZRN3	6.23e-07	186	303	10	cd6502bbf9dce318fdbb4965d49df8951e5f795c
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHOU BDNF CYS1 GRIK4 GREM2 IGF1 DCHS1 FRMPD3 CSMD1 PDZRN3	6.23e-07	186	303	10	b58db5abdd3e9f0214b198c3cbd09b0b3c321eab
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RHOU CYS1 PAPPA2 GRIK4 GREM2 IGF1 DCHS1 FRMPD3 CSMD1 PDZRN3	6.54e-07	187	303	10	8bd635abdee5d5a12a3f7bf74eab4282e8e40741
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RHOU CYS1 PAPPA2 GRIK4 GREM2 IGF1 DCHS1 FRMPD3 CSMD1 PDZRN3	6.54e-07	187	303	10	3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	COL21A1 NAV3 CACNA1D COL6A3 GRIK4 ADAMTS8 CCN1 LTBP2 TNXB PDZRN3	6.54e-07	187	303	10	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	BACH2 MCAM COL4A6 FLNC ADAMTS1 ADAMTS8 GREM2 IGF1 LTBP2 PDZRN3	7.56e-07	190	303	10	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHOU PAPPA2 COL4A6 COL6A3 GRIK4 ADAMTS8 GREM2 IGF1 CSMD1 PDZRN3	7.56e-07	190	303	10	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHOU PAPPA2 COL4A6 COL6A3 GRIK4 ADAMTS8 GREM2 IGF1 CSMD1 PDZRN3	7.56e-07	190	303	10	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	Fetal_29-31_weeks-Immune-B_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SP100 ARPP21 BACH2 SIPA1L3 STAP1 RASAL1 DOCK2 SMCHD1 CR2 IRAG2	7.93e-07	191	303	10	84452125d1b5b76974e3f9126f611eff16d45c25
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL21A1 NAV3 CACNA1D COL6A3 GRIK4 ADAMTS8 CCN1 LTBP2 TNXB PDZRN3	7.93e-07	191	303	10	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL21A1 NAV3 CACNA1D COL6A3 GRIK4 ADAMTS8 CCN1 LTBP2 TNXB PDZRN3	8.32e-07	192	303	10	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CTTNBP2 DCTN1 STARD9 HS6ST1 TDRKH GPR35 PKP4 PLXNC1 DCHS1	8.66e-07	149	303	9	a85a051e0d82430160967e72fa04b55f43e84513
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CTTNBP2 DCTN1 STARD9 HS6ST1 TDRKH GPR35 PKP4 PLXNC1 DCHS1	9.16e-07	150	303	9	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	CTTNBP2 COL21A1 NAV3 CACNA1D COL6A3 GRIK4 ADAMTS8 LTBP2 TNXB PDZRN3	9.58e-07	195	303	10	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Fibroblast-B_(Myofibroblast)\|World / shred on cell class and cell subclass (v4)	RHOU BDNF PAPPA2 COL6A3 ADAMTS8 GREM2 IGF1 CCN1 LTBP2 PDZRN3	9.58e-07	195	303	10	a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	TRIO SYT17 SIPA1L3 INTS1 IRF9 NOTCH2 ZNF687 ICAM3 TSGA10 WDR27	1.00e-06	196	303	10	7be50b9156394dea44d7b8b476d4dd516abfafae
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RHOU BDNF PAPPA2 COL6A3 ADAMTS8 IGF1 TENM4 CCN1 LTBP2 PDZRN3	1.05e-06	197	303	10	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RHOU PAPPA2 COL6A3 ADAMTS8 GREM2 IGF1 TENM4 CCN1 LTBP2 PDZRN3	1.05e-06	197	303	10	9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NAIP JAK3 DOCK2 SEMA4D SMCHD1 ARHGAP9 CR1 IGF2R PLXNC1 SORL1	1.05e-06	197	303	10	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-AT1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	SYT17 BDNF STAP1 NAV3 BAHCC1 ZFAT STAB2 PLA2G3 IGF1 NEURL1	1.05e-06	197	303	10	f7ef62d78336812573148f8bfce401877ec4e29c
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RHOU BDNF PAPPA2 COL6A3 ADAMTS8 GREM2 IGF1 CCN1 LTBP2 PDZRN3	1.05e-06	197	303	10	43b5f8e917506c1717f9311584901b506ffd2c79
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RHOU BDNF PAPPA2 COL6A3 ADAMTS8 IGF1 TENM4 CCN1 LTBP2 PDZRN3	1.05e-06	197	303	10	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PAPPA2 COL6A3 ADAMTS1 ADAMTS8 GREM2 PKIG CCN1 LTBP2 TNXB PDZRN3	1.05e-06	197	303	10	16758f181ef07c60aee63072e1da9572c5c85414
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RHOU PAPPA2 COL6A3 ADAMTS8 GREM2 IGF1 TENM4 CCN1 LTBP2 PDZRN3	1.05e-06	197	303	10	090a251194da3e2806989d9a522588f83f52da7f
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NAIP ARHGAP30 MEFV FMN1 DOCK2 CR1 TYMP PLXNC1 CD33 SORL1	1.10e-06	198	303	10	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RHOU BDNF PAPPA2 COL6A3 ADAMTS8 IGF1 TENM4 CCN1 LTBP2 PDZRN3	1.10e-06	198	303	10	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	BACH2 NAV3 CACNA1D COL6A3 GRIK4 ADAMTS8 IGF1 LTBP2 TNXB PDZRN3	1.10e-06	198	303	10	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NEB PTGFRN COL21A1 LTBP4 FLNC ADAMTS8 CCN1 P2RX6 TET1 OLFM2	1.15e-06	199	303	10	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NEB PTGFRN COL21A1 LTBP4 FLNC ADAMTS8 CCN1 P2RX6 TET1 OLFM2	1.15e-06	199	303	10	801887db51ac5dc5b068808ff75e3a46643398e9
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-B_cells\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARPP21 ARHGAP30 STAP1 DOCK2 POLD1 NFKBID CR1 CR2 IRAG2 FAM53B	1.21e-06	200	303	10	d124acbe5d46220850fe485ed78f032daddca5b1
ToppCell	LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ARPP21 BACH2 ARHGAP30 STAP1 POLD1 NFKBID CR1 CR2 IRAG2 FAM53B	1.21e-06	200	303	10	2fb3cf5c7a03c3874390a111bba15203599d4859
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-B_cells-B-cells\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARPP21 ARHGAP30 STAP1 DOCK2 POLD1 NFKBID CR1 CR2 IRAG2 FAM53B	1.21e-06	200	303	10	c07e37db9d50b91378d9c8355168745560cdbd25
ToppCell	LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells-B-cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ARPP21 BACH2 ARHGAP30 STAP1 POLD1 NFKBID CR1 CR2 IRAG2 FAM53B	1.21e-06	200	303	10	4c8007a158f0f6b6fa259b25d2387b648bb2fc0d
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL21A1 NAV3 CACNA1D COL6A3 GRIK4 ADAMTS8 CCN1 LTBP2 TNXB PDZRN3	1.21e-06	200	303	10	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BACH2 COL21A1 NAV3 CACNA1D COL6A3 GRIK4 ADAMTS8 LTBP2 TNXB PDZRN3	1.21e-06	200	303	10	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCTN1 PMM1 BAHCC1 ADAMTS1 POLD1 LLGL1 SLC38A7 LRP4 TDP1	1.83e-06	163	303	9	6b11a3ada8725670d0489f404c8c2175ad3904e9
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARPP21 EXPH5 DACT2 DDIT4L BDNF SATB2 TENM4 PDZRN3 MAST3	1.83e-06	163	303	9	431221a41d396b09170476179590eaf8a55266d8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARPP21 EXPH5 DACT2 DDIT4L BDNF SATB2 TENM4 PDZRN3 MAST3	1.83e-06	163	303	9	1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 GALNT13 STAP1 RASAL1 DOCK2 NFKBID CR2 IRAG2 CD70	2.13e-06	166	303	9	fc2cf67311c86fda75b35fcd4768b6f6f14c59d0
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 GALNT13 STAP1 RASAL1 DOCK2 NFKBID CR2 IRAG2 CD70	2.13e-06	166	303	9	33a6876d06e26176135a73a77c19e634ec53f7ce
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGAP30 SCART1 ARHGEF6 HAUS5 GTF3C1 SYTL3 PRF1 RORC SORL1	2.13e-06	166	303	9	e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	APC2 MEFV TECPR2 ADAMTSL4 SATB2 SMCHD1 ICAM3 MTMR14 SORL1	2.71e-06	171	303	9	dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	APC2 MEFV TECPR2 ADAMTSL4 SATB2 SMCHD1 ICAM3 MTMR14 SORL1	2.71e-06	171	303	9	2b7c5a557c4bc5c573211c4d618bdd6766a24916
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGAP30 NUP210 DOCK2 ARHGAP9 GRIK4 CD33 IRAG2 LINGO4 RORC	3.28e-06	175	303	9	f2c3e0f728a43d6988e793c8a50c964f7447db82
ToppCell	CV-Mild-6\|Mild / Virus stimulation, Condition and Cluster	STARD9 SATB2 MIB2 ZNF106 IGF2R WDR41 FRMPD3 ZNF839 SORL1	3.28e-06	175	303	9	c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MIS18BP1 STAP1 SCART1 ARHGAP9 PLXNC1 LINGO4 ALOXE3 RORC SORL1	3.44e-06	176	303	9	238244294d08975df6bfa26b2b437db3654408ae
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGAP30 STAP1 JAK3 LY6G6F MPO ARHGAP9 MPIG6B PRF1 RORC	3.44e-06	176	303	9	f163cc6d632112aad35a0a9217c6c99fbdd1386e
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LTBP4 COL6A3 BTBD18 GRIK4 ADAMTS8 CCN1 TET1 LRP4 TNXB	3.77e-06	178	303	9	09475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LTBP4 COL6A3 BTBD18 GRIK4 ADAMTS8 CCN1 TET1 LRP4 TNXB	3.77e-06	178	303	9	000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LTBP4 COL6A3 BTBD18 GRIK4 ADAMTS8 CCN1 TET1 LRP4 TNXB	3.77e-06	178	303	9	35de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell	ASK440-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	BACH2 ADAMTSL4 IGSF3 FLNC CYB5RL NFKBID MPIG6B DCHS1 LTBP2	3.77e-06	178	303	9	86f1741636ed3e85bb4a65f84949b718fc38c290
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYT17 TMEM132B LTBP4 COL6A3 TENM4 LRP4 LTBP2 TNXB PDZRN3	3.95e-06	179	303	9	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	BACH2 JAK3 IRF9 ICAM3 HAUS5 ARHGAP9 SYTL3 PRF1 SORL1	3.95e-06	179	303	9	db76edd368eeca05a2a5d407c3eb2f535ade0ce3
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 COL6A3 ZSWIM5 E4F1 IGF1 CCN1 SLC38A7 RORC USP54	4.32e-06	181	303	9	41969fe4d94ee77b12ecde32170aaf0b13e49644
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SP100 BACH2 SIPA1L3 STAP1 NUP210 SMCHD1 CR2 IRAG2 CD70	4.32e-06	181	303	9	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMDEC1 NAV3 IGKV3D-7 LTBP4 ANKRD35 COL6A3 GREM2 IGF1 TNXB	4.32e-06	181	303	9	e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 COL6A3 ZSWIM5 E4F1 IGF1 CCN1 SLC38A7 RORC USP54	4.32e-06	181	303	9	3f50e61dc2a52d71a5801584617607e6246adcf2
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD1 FZD6 LTBP4 HSPG2 STAB2 HSPB9 PLXNC1 BTBD7 FHDC1	4.32e-06	181	303	9	a53f05c4c47465ee62e353716456bd09ab464b23
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CTTNBP2 LTBP4 COL4A6 COL6A3 ADAMTS1 GREM2 LRP4 LTBP2 TNXB	4.32e-06	181	303	9	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)\|healthy_donor / Disease condition, Lineage, Cell class and subclass	PRSS16 HSPG2 COL6A3 ANK3 ZSWIM5 RDH5 SCUBE3 PLD6	4.80e-06	138	303	8	97f5dc17522462133e582b508ad0ef036e656872
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|368C / Donor, Lineage, Cell class and subclass (all cells)	BDH1 CARNS1 PDPR ICAM3 SYTL3 PRF1 SLC38A7 TDP1 MUTYH	4.94e-06	184	303	9	d48807f9da48bdd015a54c606d2e2a311f181396
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	VWA8 OBSCN BDNF PTPRM COL21A1 ANK3 GRIP2 CTNND2 PDZRN3	5.16e-06	185	303	9	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	COPD-Lymphoid-B\|COPD / Disease state, Lineage and Cell class	SP100 BACH2 SIPA1L3 STAP1 PPFIBP2 SMCHD1 PKIG KLHL5 CD70	5.16e-06	185	303	9	925e79c35c381dd44ec5fb921dca09ce43140135
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-iNKT-MAIT\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARPP21 SEMA4D ARHGAP9 NEURL1 CD70 SLC45A1 KIF18B CFAP46	5.34e-06	140	303	8	a8f3b01d03ee0bf0e752327a98d6b9035930c2b0
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACT2 GALNT13 FMN1 PLEKHA7 COL4A6 ANK3 TENM4 RORC USP54	5.39e-06	186	303	9	e83718fabb057100835d3357df407f283d23fe16
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	TRIO BACH2 SIPA1L3 STAP1 PPFIBP2 NFKBID CR1 PKIG CD70	5.63e-06	187	303	9	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD1 HSPG2 FLNC CYB5RL STAB2 GJC2 DIPK2B IGF1 TNXB	5.88e-06	188	303	9	26915db8863f4115b46a81982e187322e21600fd
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD1 HSPG2 FLNC CYB5RL STAB2 GJC2 DIPK2B IGF1 TNXB	5.88e-06	188	303	9	61ee7b152745164293d8a44ef91ee2393efbdca5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD1 HSPG2 FLNC CYB5RL STAB2 GJC2 DIPK2B IGF1 TNXB	5.88e-06	188	303	9	3f76c0f912f8f023ea425be7f43593b3d7f967e3
ToppCell	CTRL-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	TRIO SIPA1L3 PPFIBP2 RAPGEF1 CR1 PKIG PLXNC1 IRAG2 MAST3	6.14e-06	189	303	9	14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	SIPA1L3 LENG8 FASN FMN1 KIFC3 DOCK2 RAPGEF1 TYMP KNDC1	6.14e-06	189	303	9	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMEM132B ADAMTSL4 NOTCH2 CACNA1D PPFIBP2 GREM2 TENM4 LRP4 PDZRN3	6.14e-06	189	303	9	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	COVID-19-Heart-T_cell\|Heart / Disease (COVID-19 only), tissue and cell type	NUP210 DOCK2 SEMA4D GREM2 SYTL3 PRF1 FHDC1 CSMD1 SORL1	6.41e-06	190	303	9	e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	JAK3 NUP210 DOCK2 SEMA4D ANK3 SMCHD1 SYTL3 PRF1 SORL1	6.68e-06	191	303	9	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ARHGAP30 JAK3 NUP210 DOCK2 SEMA4D SMCHD1 ARHGAP9 SYTL3 PRF1	7.27e-06	193	303	9	326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL21A1 MOCS1 CACNA1D COL6A3 GRIK4 ADAMTS8 LTBP2 TNXB PDZRN3	7.27e-06	193	303	9	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BDNF ADAMTS1 COL20A1 ADAMTS8 GREM2 PKIG CCN1 LTBP2 PDZRN3	7.58e-06	194	303	9	6e12a7da35be4c0ecf998ef94b8989b89d74b200
ToppCell	P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	BDNF CYS1 PAPPA2 COL6A3 GRIK4 GREM2 IGF1 TENM4 CSMD1	7.58e-06	194	303	9	5f04d21c4e2d36e74b6c5889aa97fd98f75a0973
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BDNF ADAMTS1 COL20A1 ADAMTS8 GREM2 PKIG CCN1 LTBP2 PDZRN3	7.58e-06	194	303	9	c52f10140c66e8c0566421c3d535d5d92bf595e1
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SP100 TRIO SIPA1L3 HMGCS1 NEB GLYR1 SEMA4D CENPT IDS SH3D21 LLGL1 RERE CTNND2	2.07e-06	199	294	13	7029_UP
Drug	5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA	SP100 ZBTB48 EXPH5 THSD1 SRCAP TECPR2 ANK3 PLA2G3 HAUS5 CELSR3 SLC38A7 SORL1	9.41e-06	195	294	12	834_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	SP100 INTS1 SMC5 IRF9 BNIP1 NUP210 LTBP4 CACNA1D HSPG2 RNF41 CTNND2 PDZRN3	9.41e-06	195	294	12	1639_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	ZBTB48 AGBL5 ZKSCAN5 SATB2 RNF31 SMCHD1 FEM1B CCN1 SLC38A7 RNF41 CTNND2 PDZRN3	9.41e-06	195	294	12	7172_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	ZBTB48 CUL9 SPATA2 ZC3H3 PGGT1B BDNF BNIP1 NAV3 MED12 SATB2 CCN1 MAST3	9.91e-06	196	294	12	5827_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	SP100 THSD1 DCTN1 ZKSCAN5 MOCS1 RASAL1 HSPG2 TDRKH PPFIBP2 CASP6 BTBD7 CTNND2	1.04e-05	197	294	12	3319_DN
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	TRIO EXPH5 MCAM SRCAP PTPRM COL21A1 KIFC3 MPO CACNA1D TBC1D30 PRF1 TNKS2	1.10e-05	198	294	12	1529_UP
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	SP100 ZKSCAN5 IRF9 GLYR1 SPINK5 SATB2 CENPT PLA2G3 MINDY2 RPAP1 CCN1 MAST3	1.10e-05	198	294	12	6016_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SP100 PRSS16 ARHGEF11 ARHGEF17 NUP210 SEMA4D TBC1D30 MID2 IDS BTBD7 RERE CTNND2	1.15e-05	199	294	12	1502_DN
Drug	Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A	SRCAP EPX JAK3 ADAMTS9 MOCS1 SPINK5 PAPPA2 TDRKH CR1 ARHGEF40 NEURL1 ALOXE3	1.15e-05	199	294	12	3839_UP
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	BACH2 EDC4 THSD1 SRCAP DCTN1 IRF9 BNIP1 GLYR1 RNF31 FEM1B CD70 TNKS2	1.15e-05	199	294	12	6321_DN
Drug	atofluding	HEXB EPX MPO ADAMTS1 PRDX6	1.49e-05	25	294	5	CID000126342
Drug	Pummerer's ketone	EPX MPO PRDX6	2.09e-05	5	294	3	CID000099055
Drug	AC1MOE91	EPX MPO PRDX6	2.09e-05	5	294	3	CID003342294
Drug	isotrityrosine	EPX MPO PRDX6	2.09e-05	5	294	3	CID000196044
Drug	AC1Q6QQG	EPX MPO PRDX6	2.09e-05	5	294	3	CID000124376
Drug	2-chloro-1,4-dimethoxybenzene	EPX MPO PRDX6	2.09e-05	5	294	3	CID000246724
Drug	4-biphenylboronic acid	EPX MPO PRDX6	2.09e-05	5	294	3	CID000151253
Drug	t383	EPX MPO PRDX6	2.09e-05	5	294	3	CID000074847
Drug	BHAC	EPX MPO PRDX6 CD33 RERE	2.22e-05	27	294	5	CID000003228
Drug	fullerene C60	TRIO PRSS16 EXPH5 APC2 DACT2 MCAM EDC4 THSD1 SRCAP RNF187 ARHGEF11 DCTN1 FAM13B BDH1 DNASE2B HS6ST1 SLMAP EXOC3L1 KIFC3 ADAMTSL4 MOCS1 NOTCH2 IGSF3 CACNA1D AMPD2 SATB2 COL20A1 HES3 OPRD1 GREM2 IGF1 TENM4 LLGL1 GTF3C1 MTMR14 CCN1 RORC OLFM2 PAX6	2.36e-05	1498	294	39	ctd:C069837
Drug	2,6-dimethoxyphenol	EPX BDH1 IRF9 MPO WASL PRDX6 GTF3C1	2.76e-05	68	294	7	CID000007041
Drug	troglitazone; Down 200; 10uM; PC3; HT_HG-U133A	SIPA1L3 ARHGEF11 BDNF NAV3 LTBP4 MOCS1 BAHCC1 SEMA4D GPR37 HAUS5 CCN1	3.53e-05	188	294	11	4456_DN
Drug	5-hydroxyconiferyl alcohol	EPX MPO PRDX6	4.14e-05	6	294	3	CID005282095
Drug	PPHP	EPX MPO PRDX6	4.14e-05	6	294	3	CID006438577
Drug	4-methoxymandelic acid	EPX MPO PRDX6	4.14e-05	6	294	3	CID000112056
Drug	pulcherosine	EPX MPO PRDX6	4.14e-05	6	294	3	CID000124402
Drug	indamine	EPX MPO PRDX6	4.14e-05	6	294	3	CID000010841
Drug	biotinyl-L-lysine	PRSS16 EPX GRIN3B MPO TNPO1 GJC2 PRDX6 OPRD1	4.35e-05	99	294	8	CID000083814
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A	SRCAP NOTCH2 TDRKH CYB5RL TBC1D30 PLA2G3 MINDY2 BTBD7 LTBP2 RERE SORL1	4.49e-05	193	294	11	1464_DN
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SP100 EPX ARHGEF17 LTBP4 MOCS1 BAHCC1 HSPG2 STAB2 PLA2G3 LLGL1 TNKS2	4.49e-05	193	294	11	5271_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ZBTB48 TRIO THSD1 BNIP1 NOTCH2 RASAL1 BAHCC1 TBC1D30 PLA2G3 RPAP1 CCN1	4.93e-05	195	294	11	4975_DN
Drug	Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A	TRIO THSD1 SRCAP NAV3 MOCS1 COL4A6 SEMA4D CENPT ADAMTS1 IDS CCN1	4.93e-05	195	294	11	4324_DN
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A	VWA8 SYT17 HMGCS1 THSD1 BNIP1 TRPV6 SEMA4D TDRKH ADAMTS1 FEM1B RORC	5.16e-05	196	294	11	6863_DN
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	APC2 PSMD4 EPX JAK3 ADAMTS9 TRPV6 PAPPA2 LLGL1 LRP4 CD70 RORC	5.40e-05	197	294	11	3924_UP
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	SP100 VWA8 CUL9 MOCS1 CACNA1D HSPG2 STAB2 PLA2G3 IDS BTBD7 PRF1	5.66e-05	198	294	11	2305_DN
Drug	Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A	TRIO CUL9 EPX ARHGEF11 BDNF ARHGEF6 COL4A6 COL6A3 TEX14 TENM4 TNKS2	5.66e-05	198	294	11	3879_UP
Drug	2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A	MCAM HMGCS1 PTPRM TECPR2 GLYR1 MOCS1 SEMA4D STAB2 LLGL1 IRAG2 MAST3	5.66e-05	198	294	11	5211_UP
Drug	aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A	SRCAP ARHGEF17 TECPR2 TRPV6 PAPPA2 TSGA10 ADAMTS8 PRF1 NEURL1 CTNND2 PDZRN3	5.66e-05	198	294	11	4428_UP
Drug	Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; HL60; HT_HG-U133A	CUL9 ARHGEF11 DCTN1 ZKSCAN5 GLYR1 BAHCC1 ANK3 PPFIBP2 IDS TYMP MAST3	5.92e-05	199	294	11	3138_DN
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; HL60; HT_HG-U133A	SRCAP NEB NOTCH2 PAPPA2 ADAMTS1 CR1 FEM1B RPAP1 SLC38A7 ZNF839 BBC3	5.92e-05	199	294	11	2408_DN
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A	TRIO SIPA1L3 SRCAP NEB TECPR2 LTBP4 PPFIBP2 SH3D21 CD70 RERE MAST3	6.19e-05	200	294	11	4953_UP
Drug	Milrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A	HMGCS1 ARHGEF17 MOCS1 NOTCH2 TBC1D30 PLA2G3 IDS MINDY2 BTBD7 CTNND2 TNKS2	6.19e-05	200	294	11	3552_DN
Drug	propylthiouracil	A1BG EPX LY6G6F MED12 IGSF3 MPO IDS PRDX6 IGF1	6.67e-05	135	294	9	CID000657298
Drug	3-(3,4-dimethoxyphenyl) acrylate	EPX MPO PRDX6	7.18e-05	7	294	3	CID000016848
Drug	N-(carboxyheptyl)maleimide	EPX MPO PRDX6	7.18e-05	7	294	3	CID000092656
Drug	benzidinediimine	EPX MPO PRDX6	7.18e-05	7	294	3	CID000115267
Drug	asarol methyl ether	EPX MPO PRDX6	7.18e-05	7	294	3	CID000097686
Drug	AC1L3RVN	EPX MPO PRDX6	1.14e-04	8	294	3	CID000094274
Drug	pyrachlostrobin	HEXB DACT2 DDIT4L MCAM FZD6 ADAMTS9 TRPV6 PLEKHA7 ADAMTSL4 NOTCH2 COL4A6 HSPG2 FLNC SPATA6 ADAMTS1 GPR35 PRDX6 CCN1 LRP4 FAM53B LTBP2 KIF18B EPHA10 SORL1	1.51e-04	811	294	24	ctd:C513428
Drug	tryptophan	EPX MPO CALCA PRDX6	1.66e-04	22	294	4	CID005460840
Drug	2-bromohexadecanal	EPX MPO	1.66e-04	2	294	2	CID015701742
Drug	bromine trichloride	EPX MPO	1.66e-04	2	294	2	CID003014687
Drug	AC1L22VU	EPX MPO	1.66e-04	2	294	2	CID000040008
Drug	MLD987	EPX MPO	1.66e-04	2	294	2	CID006918516
Drug	AC1O5E2B	EPX MPO PRDX6	1.69e-04	9	294	3	CID002724224
Drug	isothiocyanato thiocyanate	EPX MPO PAX6	1.69e-04	9	294	3	CID000521282
Drug	deuterohemin	EPX MPO PRDX6	1.69e-04	9	294	3	CID003082177
Drug	m-phenylenediamine	EPX MPO PRDX6 CD70	1.99e-04	23	294	4	CID000007935
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SYT17 SIPA1L3 NEB CACNA1D ANK3 RNF31 PLA2G3 TSGA10 CELSR3 CCN1	1.99e-04	191	294	10	4969_DN
Drug	Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A	THSD1 DCTN1 CACNA1D SEMA4D IDS MINDY2 BTBD7 SLC38A7 EP300 SORL1	1.99e-04	191	294	10	6839_DN
Drug	resorcinol	EPX PRMT5 MPO TCF20 PRDX6	2.00e-04	42	294	5	CID000005054
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; PC3; HT_HG-U133A	BDH1 NUP210 NAV3 ADAMTS1 IDS FEM1B MTF1 CD70 ZNF839 EP300	2.08e-04	192	294	10	2078_DN
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A	ZBTB48 SIPA1L3 GLYR1 BAHCC1 HSPG2 TDRKH TBC1D30 PRF1 ALOXE3 LTBP2	2.17e-04	193	294	10	5608_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ZKSCAN5 IRF9 TECPR2 GLYR1 NUP210 MED12 GPR37 IDS PDZRN3 MUTYH	2.26e-04	194	294	10	7406_DN
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	TRIO SYT17 SMC5 NUP210 LTBP4 TNPO1 HSPG2 WASL IGF2R SLC38A7	2.26e-04	194	294	10	6921_UP
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A	SRCAP NEB ARHGEF11 ARHGEF17 GLYR1 TRPV6 RASAL1 STAB2 PLA2G3 PLXNC1	2.35e-04	195	294	10	3909_DN
Drug	Thiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT_HG-U133A	TRIO NEB NOTCH2 CACNA1D ATG7 PLA2G3 FEM1B BTBD7 CTNND2 TNKS2	2.35e-04	195	294	10	5520_DN
Drug	Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	SIPA1L3 INTS1 SRCAP CBLIF JAK3 ADAMDEC1 DNAH2 RAPGEF1 CD70 ALOXE3	2.35e-04	195	294	10	4746_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	INTS1 TECPR2 MED12 BAHCC1 HSPG2 TEX14 TENM4 LRP4 LTBP2 MAST3	2.35e-04	195	294	10	2805_UP
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	SIPA1L3 EDC4 ZKSCAN5 BDNF CENPT TBC1D30 RPAP1 GTF3C1 RNF41 MAST3	2.35e-04	195	294	10	1207_DN
Drug	Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	TECPR2 NUP210 PKP4 HAUS5 FEM1B CELSR3 CCN1 RNF41 TNKS2 SORL1	2.35e-04	195	294	10	7451_DN
Drug	trityrosine	EPX MPO PRDX6	2.39e-04	10	294	3	CID000164782
Drug	3-dimethylaminobenzoic acid	EPX MPO PRDX6	2.39e-04	10	294	3	CID000066837
Drug	naphthol AS-MX	EPX MPO PRDX6	2.39e-04	10	294	3	CID000066717
Drug	cymarose	FASN ADAMTS1 CR2	2.39e-04	10	294	3	CID000441417
Drug	1,4-dimethoxybenzene	EPX MPO PRDX6	2.39e-04	10	294	3	CID000009016
Drug	ovothiol	EPX MPO PRDX6	2.39e-04	10	294	3	CID000129029
Drug	1,2,5,6-dibenzanthracene	DDIT4L THSD1 RHOU FZD6 FASN CYS1 ADAMDEC1 PLEKHA7 CAD STAB2 TBC1D30 TYMP GREM2 PKIG KLHL5 IGF1 CCN1 DCHS1 SCUBE3 PLD6 FAM53B LTBP2 CTNND2 BBC3	2.41e-04	837	294	24	ctd:C026486
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	MCAM HMGCS1 SRCAP NEB ARHGEF17 TRPV6 LTBP4 PAPPA2 TDRKH RPAP1	2.45e-04	196	294	10	5568_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	AGBL5 ARHGEF11 DCTN1 MED12 HAUS5 FAM53B BBC3 PDZRN3 MAST3 SORL1	2.45e-04	196	294	10	7181_DN
Drug	Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A	ARHGEF11 JAK3 DNASE2B PAPPA2 TEX14 LLGL1 CCN1 LRP4 CD70 PCDHGC3	2.45e-04	196	294	10	3387_UP
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	SIPA1L3 CUL9 ARHGEF11 CBLIF TECPR2 MOCS1 NOTCH2 CYB5RL CELSR3 CCN1	2.45e-04	196	294	10	3233_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	ZBTB48 TRIO INTS1 GLYR1 LTBP4 SPINK5 HAUS5 CASP6 SH3D21 MAST3	2.45e-04	196	294	10	3409_UP
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	NEB ARHGEF11 TECPR2 GLYR1 LTBP4 SEMA4D HSPG2 TDRKH BTBD7 LTBP2	2.45e-04	196	294	10	4366_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; PC3; HT_HG-U133A	SP100 BACH2 HMGCS1 GLYR1 NUP210 GPR37 FEM1B BTBD7 RNF41 TNKS2	2.45e-04	196	294	10	6631_DN
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA	ARHGEF11 IRF9 GLYR1 RNF31 HECTD3 HAUS5 IDS FAM53B BBC3 EP300	2.45e-04	196	294	10	1041_UP
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A	CUL9 CBLIF JAK3 BAHCC1 CENPT PKP4 PLA2G3 IDS PRF1 NEURL1	2.45e-04	196	294	10	6305_UP
Drug	Retrorsine [480-54-6]; Down 200; 11.4uM; PC3; HT_HG-U133A	MIS18BP1 ZBTB48 BDH1 TBCB NAV3 TRPV6 NOTCH2 SLC38A7 CD70 ZNF839	2.45e-04	196	294	10	6601_DN
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A	MCAM SRCAP KIFC3 NOTCH2 TBC1D30 ARHGEF40 CD70 ALOXE3 RNF41 WDR41	2.45e-04	196	294	10	1912_UP
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A	SIPA1L3 EDC4 SPATA2 PGGT1B NAV3 COL4A6 RSBN1 TNKS2 ZNF839 MAST3	2.55e-04	197	294	10	5819_DN
Drug	0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A	SIPA1L3 SRCAP CBLIF SLC49A3 LTBP4 PAPPA2 TDRKH TBC1D30 PLA2G3 CR1	2.55e-04	197	294	10	6389_DN
Drug	Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; MCF7; HT_HG-U133A	TECPR2 LTBP4 SPINK5 CACNA1D MID2 PPFIBP2 CR1 BTBD7 ALOXE3 RERE	2.55e-04	197	294	10	3401_DN
Drug	Estriol [50-27-1]; Down 200; 13.8uM; HL60; HT_HG-U133A	SP100 THSD1 AGBL5 NEB ZKSCAN5 TRPV6 PPFIBP2 CR1 SLC38A7 TNKS2	2.55e-04	197	294	10	6140_DN
Drug	Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A	VWA8 CUL9 SRCAP HSPG2 TDRKH RNF31 HAUS5 IDS BTBD7 CTNND2	2.55e-04	197	294	10	1463_DN
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	CUL9 ARHGEF17 HSPG2 GPR35 TEX14 ARHGEF40 CD70 ALOXE3 RORC MAST3	2.55e-04	197	294	10	4138_UP
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	TRIO JAK3 TECPR2 BAHCC1 PAPPA2 FEM1B CELSR3 NEURL1 ALOXE3 LTBP2	2.55e-04	197	294	10	7500_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	EXPH5 ARHGEF11 PGGT1B LTBP4 CACNA1D HSPG2 GPR37 BTBD7 EP300 MAST3	2.55e-04	197	294	10	1640_DN
Drug	Estrone [53-16-7]; Down 200; 14.8uM; HL60; HT_HG-U133A	SRCAP ARHGEF11 ZC3H3 BAHCC1 ANK3 TBC1D30 FEM1B PKIG LTBP2 BBC3	2.55e-04	197	294	10	3071_DN
Drug	Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SYT17 SRCAP EPX JAK3 COL21A1 RASAL1 WASL PPFIBP2 CR1 BTBD7	2.55e-04	197	294	10	2898_UP
Disease	Familial Alzheimer Disease (FAD)	BDNF MPO ADAMTS1 CR1 IGF1 IGF2R CD33 SORL1	6.90e-06	100	291	8	C0276496
Disease	Alzheimer's Disease	BDNF MPO ADAMTS1 CR1 IGF1 IGF2R CD33 SORL1	7.43e-06	101	291	8	C0002395
Disease	Acute Confusional Senile Dementia	BDNF MPO ADAMTS1 CR1 IGF1 IGF2R CD33	5.79e-05	99	291	7	C0546126
Disease	Alzheimer Disease, Late Onset	BDNF MPO ADAMTS1 CR1 IGF1 IGF2R CD33	5.79e-05	99	291	7	C0494463
Disease	Alzheimer's Disease, Focal Onset	BDNF MPO ADAMTS1 CR1 IGF1 IGF2R CD33	5.79e-05	99	291	7	C0750900
Disease	Alzheimer Disease, Early Onset	BDNF MPO ADAMTS1 CR1 IGF1 IGF2R CD33	5.79e-05	99	291	7	C0750901
Disease	Presenile dementia	BDNF MPO ADAMTS1 CR1 IGF1 IGF2R CD33	5.79e-05	99	291	7	C0011265
Disease	alopecia (is_marker_for)	BDNF IGF1	9.69e-05	2	291	2	DOID:987 (is_marker_for)
Disease	Depression, Bipolar	BDNF STARD9 CACNA1D ANK3 GRIK4 TENM4	1.33e-04	79	291	6	C0005587
Disease	neuropsychological test	SP100 BACH2 TARBP1 TBC1D30 GRIK4 IDS TENM4 GRIP2 CSMD1	1.59e-04	197	291	9	EFO_0003926
Disease	FEV/FEC ratio	CTTNBP2 BACH2 DDIT4L NEB ARHGEF17 PTPRM COL21A1 SLMAP LTBP4 EEFSEC CACNA1D HSPG2 COL6A3 ADAMTS1 SH3D21 GREM2 ZNF106 RPAP1 NEURL1 SCUBE3 LTBP2 WDR41 CSMD1 TNXB PDZRN3 SORL1	2.30e-04	1228	291	26	EFO_0004713
Disease	Deletion 11p13	BDNF PAX6	2.89e-04	3	291	2	C2931803
Disease	WAGR Syndrome	BDNF PAX6	2.89e-04	3	291	2	C0206115
Disease	pulse pressure measurement	CWF19L2 SRCAP EPX SSPOP FASN BNIP1 COL21A1 PKD1 STAMBPL1 PLEKHA7 PAPPA2 CACNA1D COL6A3 ZFAT PDPR ATG7 WNT9B ADAMTS8 TENM4 CCN1 MTF1 PLXNC1 TET1 SLC38A7 FAM53B MYEOV LTBP2 CTNND2	3.04e-04	1392	291	28	EFO_0005763
Disease	non-melanoma skin carcinoma	PRSS16 BACH2 RHOU HERC2 ZAN ATG7 DNAH2 MPIG6B RSBN1 RORC	3.26e-04	265	291	10	EFO_0009260
Disease	Squamous cell carcinoma of esophagus	FASN NOTCH2 TYMP KMT2D TNXB EP300	3.64e-04	95	291	6	C0279626
Disease	neurotic disorder	ARPP21 CTTNBP2 PAX6 RERE CSMD1 TNXB	5.06e-04	101	291	6	EFO_0004257
Disease	Psychotic Disorders	BDNF MED12 ANK3 GRIK4 TENM4 TET1	5.06e-04	101	291	6	C0033975
Disease	cataract (implicated_via_orthology)	SIPA1L3 INTS1 DNASE2B PAX6	5.25e-04	38	291	4	DOID:83 (implicated_via_orthology)
Disease	Liver carcinoma	TRIP13 FASN MPO STAB2 ATG7 ADAMTS1 PRDX6 DIPK2B IGF1 IGF2R CELSR3 CCN1 CSMD1 KIF18B	5.65e-04	507	291	14	C2239176
Disease	Nonorganic psychosis	MED12 ANK3 GRIK4 TENM4 TET1	6.05e-04	69	291	5	C0349204
Disease	Colorectal Carcinoma	APC2 OBSCN MPO COL4A6 FLNC SATB2 CAD POLD1 TYMP RPAP1 NEURL1 DCHS1 OLFM2 CTNND2 EP300 MUTYH SORL1	6.68e-04	702	291	17	C0009402
Disease	Manic Disorder	BDNF STARD9 CACNA1D ANK3 TENM4	6.90e-04	71	291	5	C0024713
Disease	late-onset Alzheimers disease	SLMAP KIFC3 ANK3 ADAMTS1 CR1 MINDY2 TENM4 CD33 CTNND2 SORL1	6.94e-04	292	291	10	EFO_1001870
Disease	colorectal health	VWA8 EXPH5 GALNT13 GLYR1 HERC2 ZFAT ADAMTS1 CSMD1	9.06e-04	201	291	8	EFO_0008460
Disease	Malignant Cystosarcoma Phyllodes	MED12 KMT2D	9.50e-04	5	291	2	C0600066
Disease	scoliosis (implicated_via_orthology)	SSPOP ADAMTS9	9.50e-04	5	291	2	DOID:0060249 (implicated_via_orthology)
Disease	migraine disorder, type 1 diabetes mellitus	RERE SLC45A1	9.50e-04	5	291	2	MONDO_0005147, MONDO_0005277
Disease	Phyllodes Tumor	MED12 KMT2D	9.50e-04	5	291	2	C0010701
Disease	Deafness, Acquired	BDNF CACNA1D POLD1	9.56e-04	20	291	3	C0751068
Disease	Hearing Loss, Extreme	BDNF CACNA1D POLD1	9.56e-04	20	291	3	C0086395
Disease	Prelingual Deafness	BDNF CACNA1D POLD1	9.56e-04	20	291	3	C0011052
Disease	Deaf Mutism	BDNF CACNA1D POLD1	9.56e-04	20	291	3	C4082305
Disease	Complete Hearing Loss	BDNF CACNA1D POLD1	9.56e-04	20	291	3	C0581883
Disease	Bilateral Deafness	BDNF CACNA1D POLD1	9.56e-04	20	291	3	C3665473
Disease	Corneal astigmatism	SYT17 DACT2 HERC2 ADAMTS8 CTNND2	9.98e-04	77	291	5	EFO_1002040
Disease	Manic	BDNF STARD9 CACNA1D ANK3 TENM4	1.06e-03	78	291	5	C0338831
Disease	Autistic Disorder	VWA8 BDNF MAGEL2 CALCA NTF4 IGF1 MTF1 PRF1 PAX6	1.21e-03	261	291	9	C0004352
Disease	risk-taking behaviour	ARPP21 BACH2 CUL9 TMEM132B BDNF PTPRM BAHCC1 PAPPA2 CACNA1D SEMA4D TCF20 CASP6 TENM4 LRP4 TNXB EP300 SORL1	1.66e-03	764	291	17	EFO_0008579
Disease	cortical thickness	CTTNBP2 CUL9 ADAMTS9 COL21A1 GLYR1 PKD1 NAV3 PLEKHA7 SEMA4D HSPG2 SATB2 ADAMTS8 MINDY2 ZNF106 NPRL2 ARHGEF40 PLXNC1 LRP4 FAM53B MYEOV RERE ATOH1	1.68e-03	1113	291	22	EFO_0004840
Disease	intraocular pressure measurement	CTTNBP2 HERC2 PLEKHA7 COL6A3 WNT9B GRIK4 ADAMTS8 ZNF106 IGF1 NEURL1 LRP4 LTBP2 TNXB	1.77e-03	509	291	13	EFO_0004695
Disease	Deafness	BDNF CACNA1D POLD1	1.86e-03	25	291	3	C0011053
Disease	tumor necrosis factor receptor superfamily member 6 measurement	FASN STAMBPL1	1.97e-03	7	291	2	EFO_0010610
Disease	uveal melanoma disease severity	BDH1 STAP1	1.97e-03	7	291	2	EFO_0010244
Disease	atrioventricular septal defect (implicated_via_orthology)	GLYR1 CCN1	1.97e-03	7	291	2	DOID:0050651 (implicated_via_orthology)
Disease	ankylosing spondylitis	BACH2 MEFV FASN GPR35 CSMD1	2.10e-03	91	291	5	EFO_0003898
Disease	Abnormality of the skeletal system	APC2 INTS1	2.61e-03	8	291	2	C4021790
Disease	disease recurrence, malaria	PTPRM KNDC1	2.61e-03	8	291	2	EFO_0001068, EFO_0004952
Disease	Bladder Neoplasm	NOTCH2 MPO TYMP KMT2D IGF1 EP300	2.72e-03	140	291	6	C0005695
Disease	Malignant neoplasm of urinary bladder	NOTCH2 MPO TYMP KMT2D IGF1 EP300	2.82e-03	141	291	6	C0005684
Disease	vital capacity	PRSS16 BDNF GHSR COL21A1 SLMAP CARNS1 LTBP4 ARHGEF6 PAPPA2 SEMA4D HSPG2 COL6A3 ZFAT TCF20 ADAMTS1 WDR27 ADAMTS8 ZNF106 IGF1 MTF1 LTBP2 WDR41 TNXB	2.83e-03	1236	291	23	EFO_0004312
Disease	Breast Carcinoma	APC2 RNF115 FASN ZC3H11A HERC2 MED12 NOTCH2 ADAMTS1 ZSWIM5 KMT2D IGF1 LLGL1 EP300	2.86e-03	538	291	13	C0678222
Disease	colorectal cancer (implicated_via_orthology)	APC2 NOTCH2 POLD1	3.16e-03	30	291	3	DOID:9256 (implicated_via_orthology)
Disease	respiratory system disease	BACH2 EEFSEC PLXNC1 SCUBE3 RORC RERE	3.24e-03	145	291	6	EFO_0000684
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	ANK3 TENM4 NEURL1 RERE CSMD1	3.30e-03	101	291	5	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	acoustic neuroma (is_marker_for)	BDNF IGF1	3.33e-03	9	291	2	DOID:12689 (is_marker_for)
Disease	Mental deterioration	CR1 SORL1	3.33e-03	9	291	2	C0234985
Disease	Mild cognitive disorder	CR1 SORL1	3.33e-03	9	291	2	C1270972
Disease	uveal melanoma (is_marker_for)	MCAM IGF1	3.33e-03	9	291	2	DOID:6039 (is_marker_for)
Disease	IGF-1 measurement	AGBL5 SRCAP GHSR STARD9 CARNS1 PAPPA2 STAB2 C2CD4A ADAMTS8 OPRD1 IGF1 IGF2R	3.56e-03	488	291	12	EFO_0004627
Disease	chronic obstructive pulmonary disease	TPRN BACH2 DDIT4L ARHGEF17 COL21A1 SLMAP LTBP4 TNPO1 EEFSEC CACNA1D COL6A3 LINC02693 TENM4 LLGL1 RPAP1	3.70e-03	688	291	15	EFO_0000341
Disease	Mental Retardation, X-Linked 1	MED12 ARHGEF6 MID2	3.81e-03	32	291	3	C2931498
Disease	Odontome	LRP4 PAX6	4.14e-03	10	291	2	C0524730
Disease	PRADER-WILLI SYNDROME	HERC2 MAGEL2	4.14e-03	10	291	2	176270
Disease	Tooth Abnormalities	LRP4 PAX6	4.14e-03	10	291	2	C0040427
Disease	lactose measurement	ZNF106 CSMD1	4.14e-03	10	291	2	EFO_0010507
Disease	Prader-Willi syndrome	HERC2 MAGEL2	4.14e-03	10	291	2	cv:C0032897
Disease	chronic obstructive pulmonary disease, chronic bronchitis	CYS1 CSMD1	4.14e-03	10	291	2	EFO_0000341, EFO_0006505
Disease	transient cerebral ischemia (biomarker_via_orthology)	GHSR ADAMTS1 IGF1 PAX6 BBC3 EP300	4.77e-03	157	291	6	DOID:224 (biomarker_via_orthology)
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	ATOH1 EPHA10	5.03e-03	11	291	2	DOID:0050564 (is_implicated_in)
Disease	Umbilical hernia	FMN1 NAV3	5.03e-03	11	291	2	HP_0001537
Disease	Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement	SHKBP1 ANK3	5.03e-03	11	291	2	EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175
Disease	visceral:subcutaneous adipose tissue ratio	BACH2 SCART1 CACNA1D ZFAT	5.10e-03	70	291	4	EFO_0004767
Disease	multiple myeloma (is_marker_for)	NOTCH2 IGF2R CCN1	5.33e-03	36	291	3	DOID:9538 (is_marker_for)
Disease	thyroid peroxidase antibody measurement	CTTNBP2 BACH2 MIR7-3HG RERE	5.64e-03	72	291	4	EFO_0005666
Disease	Royer Syndrome	HERC2 MAGEL2	5.99e-03	12	291	2	C0265222
Disease	Neurogenic Inflammation	MCAM CALCA	5.99e-03	12	291	2	C0600467
Disease	polycystic ovary syndrome (is_marker_for)	NCOA4 IGF1	5.99e-03	12	291	2	DOID:11612 (is_marker_for)
Disease	intracranial aneurysm (is_implicated_in)	PKD1 KMT2D	5.99e-03	12	291	2	DOID:10941 (is_implicated_in)
Disease	Abruptio Placentae	GALNT13 DOCK2	5.99e-03	12	291	2	EFO_1001754
Disease	childhood onset asthma	ARPP21 BACH2 IGSF3 EEFSEC TDRKH KLHL5 SCUBE3 RORC RERE	6.21e-03	334	291	9	MONDO_0005405
Disease	monocyte count	SP100 PSMD4 RIPOR3 ARHGAP30 PTGFRN LY6G6F PKD1 EXOC3L1 MPO TNPO1 EEFSEC STAB2 CLASP1 GPR35 OSER1 ARHGAP9 HSPB9 RSBN1 KLHL5 CD33 MYEOV BBC3 SORL1	6.22e-03	1320	291	23	EFO_0005091
Disease	Mammary Carcinoma, Human	APC2 RNF115 FASN ZC3H11A MED12 NOTCH2 ADAMTS1 ZSWIM5 KMT2D IGF1 LLGL1 EP300	6.29e-03	525	291	12	C4704874
Disease	Mammary Neoplasms, Human	APC2 RNF115 FASN ZC3H11A MED12 NOTCH2 ADAMTS1 ZSWIM5 KMT2D IGF1 LLGL1 EP300	6.29e-03	525	291	12	C1257931
Disease	Mammary Neoplasms	APC2 RNF115 FASN ZC3H11A MED12 NOTCH2 ADAMTS1 ZSWIM5 KMT2D IGF1 LLGL1 EP300	6.48e-03	527	291	12	C1458155
Disease	Parkinson disease, disease progression measurement	GPR32 GPR32P1 ZNF106	6.67e-03	39	291	3	EFO_0008336, MONDO_0005180
Disease	obsolete aging	CTTNBP2 EPX RHOU COL6A3 ADAMTS1 ZNF106 LTBP2 RERE	6.76e-03	279	291	8	GO_0007568
Disease	colon carcinoma (is_marker_for)	KMT2D IGF2R	7.04e-03	13	291	2	DOID:1520 (is_marker_for)
Disease	Prader-Willi Syndrome	HERC2 MAGEL2	7.04e-03	13	291	2	C0032897
Disease	3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement	TENM4 MYEOV	7.04e-03	13	291	2	EFO_0021053
Disease	brain cortex volume measurement	CWF19L2 COL6A3	7.04e-03	13	291	2	EFO_0010287
Disease	cutaneous melanoma	BACH2 FMN1 HERC2 GPR37 RAPGEF1	7.08e-03	121	291	5	EFO_0000389
Disease	Lymphoma	JAK3 NOTCH2 PRF1	7.16e-03	40	291	3	C0024299
Disease	Leukemia, Myelocytic, Acute	TRIO BACH2 NOTCH2 CD33 SLX4 EP300	7.58e-03	173	291	6	C0023467
Disease	Neoplasm of uncertain or unknown behavior of breast	HERC2 NOTCH2 EP300	7.67e-03	41	291	3	C0496956
Disease	Breast adenocarcinoma	HERC2 NOTCH2 EP300	7.67e-03	41	291	3	C0858252
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 FLNC	8.16e-03	14	291	2	DOID:898 (implicated_via_orthology)
Disease	vascular dementia (biomarker_via_orthology)	BDNF IGF1	8.16e-03	14	291	2	DOID:8725 (biomarker_via_orthology)
Disease	diabetic neuropathy (implicated_via_orthology)	BDNF IGF1	8.16e-03	14	291	2	DOID:9743 (implicated_via_orthology)
Disease	glucose-dependent insulinotropic peptide measurement, glucose tolerance test	ARHGEF17 PAPPA2	8.16e-03	14	291	2	EFO_0004307, EFO_0008464

Protein segments in the cluster

Peptide	Gene	Start	Entry
LERCRLGAESPSIAS	PKP4	66	Q99569
SAEVTPDLQSRGELC	NAIP	351	Q13075
GLPVSCSENTLSRAR	AGBL5	626	Q8NDL9
TPRTRESSELELGSC	AGBL5	811	Q8NDL9
RLRPTAVAGSAVCAE	CYS1	96	Q717R9
SPELLQSVCERTGRF	EXOC3L1	556	Q86VI1
SPGDSRRLSIQRCIQ	EP300	1726	Q09472
TAPAGAACLERSRSV	BACH2	321	Q9BYV9
ERQGLLGACRLSSPE	BAHCC1	1706	Q9P281
TADLLAARERSCPAS	CCR10	271	P46092
QSLVSPGSCLEDFRA	COL4A6	1616	Q14031
LLREAGPELSSECRA	ARHGEF40	1221	Q8TER5
EDQLSERPCGRSSSL	ARHGEF6	111	Q15052
EQLNRLIRGPASCSS	ARHGEF6	541	Q15052
IPRCSGESEQLRACS	ADAMTSL4	361	Q6UY14
DPARRGELSVCDSIS	BDNF	131	P23560
QLRGSPERTCLLNGS	CSMD1	2951	Q96PZ7
QITNERGEPSCDRLT	CTAGE6	571	Q86UF2
QITNERGEPSCDRLT	CTAGE15	571	A4D2H0
ELSENCSERPGLRGA	DCTN1	631	Q14203
SRLPGKTLSACDREN	BDH1	11	Q02338
KTLSACDRENGARRP	BDH1	16	Q02338
ECETRALSSPGELQA	ARID3C	201	A6NKF2
VNGEPESLAAVSLCR	ADAMTS8	106	Q9UP79
AQLGACTRPVDVRDS	BBC3	226	Q96PG8
GISTRVTNDNPECRL	CCN1	246	O00622
CSDRQPGVLTRDRSC	GPR32	11	O75388
GRRSIESPSLGFCTD	ARHGEF11	676	O15085
CPSTSLDGENRGIRT	ARHGEF11	1166	O15085
RLALNSPSVSGELAC	CFAP46	1186	Q8IYW2
EECRERSTLGRPQCT	CD300LD-AS1	181	Q96MU5
RDLTCPTGASAELAR	CARNS1	71	A5YM72
DVLRLSSTEPCGLRG	DDIT4L	91	Q96D03
DCLPADLVGERSAQS	ANKRD35	706	Q8N283
PSGSEEAILQCLRDA	DNHD1	2916	Q96M86
LDVAEPGPSRCRSDS	AMPD2	31	Q01433
CGRFLVSTSTRPLQE	DIPK2B	241	Q9H7Y0
CTIASQRLTPLARGD	CD70	151	P32970
QRLTPLARGDTLCTN	CD70	156	P32970
SCIRSLQESGILDPQ	CTNND2	126	Q9UQB3
TRSLAVCEESSARPG	ARPP21	66	Q9UBL0
CDLKSRLDSRTGVAP	HMGCS1	406	Q01581
DVSRPDSQGRLCPAS	MROH7	111	Q68CQ1
ADTGACPEVLARQRA	RASAL1	756	O95294
DNSLRRAAEGISCPS	PDZRN3	776	Q9UPQ7
PAQSTCSRDGRSREL	OLFM2	51	O95897
APASRRGELAVCDAV	NTF4	86	P34130
TLECVSAGEPRSSAR	HSPG2	3131	P98160
PSRSCSVIEDDGLQA	ADAMTS1	381	Q9UHI8
ETCSTLAESPRNGLQ	EDC4	836	Q6P2E9
LPNGALACSLQRRES	FMN1	221	Q68DA7
IPQRSCSLLSTEAGA	JAK3	11	P52333
PSCSARELAEAAARL	KCNJ9	331	Q92806
RTLARSRPQTQGEDC	NOBOX	171	O60393
EPRSADDSLSGVVRC	LLGL1	711	Q15334
LSARAADGSPCNVLL	LY6G6F	131	Q5SQ64
TRDSLSNATPCAVLR	NOSIP	226	Q9Y314
TCVAPLSGVDFQLRR	A1BG	231	P04217
RPGSSLLDQDCRPDS	ARHGEF17	296	Q96PE2
GARPCDISRILQVSN	PAX6	36	P26367
VGDRSSNLRGECTPT	NUP210	1581	Q8TEM1
SNLRGECTPTQREVI	NUP210	1586	Q8TEM1
LTLDCSEGTDSRPRG	FHDC1	781	Q9C0D6
SARLTCTLPSDINVG	IGLV5-37	36	A0A075B6J1
PNVSCDIAASRRGVL	NOTCH2	1101	Q04721
GDVCTTRTLDRDQGP	DCHS1	636	Q96JQ0
ETSRADCLGAPNIRT	MIR7-3HG	31	Q8N6C7
VAAAVGSRSPEECQR	MIS18BP1	906	Q6P0N0
TPSGECRASSIDRRG	MAGEL2	716	Q9UJ55
ATLRSGEQCSVEPDL	INTS1	1526	Q8N201
LSPGERATLSCRASQ	IGKV3D-7	36	A0A0C4DH55
PNSCLLAALSDRETR	MTMR14	586	Q8NCE2
DRDRDSSPCVGLPAA	GJC2	366	Q5T442
RALSALLPCAVSGNE	HERC2	906	O95714
NRSIVPRLAASLAAC	HERC2	3746	O95714
SDLCPRVLSTQARDR	NFKBID	171	Q8NI38
NGRLSCTRESDPVRD	SPINK5	716	Q9NQ38
ESRVASRCPSVGLAE	HSPB9	11	Q9BQS6
VELRPGTARTICQDS	ALOXE3	111	Q9BYJ1
RLLGDPSRNNCSLSI	CD33	91	P20138
APGLCRDEQSSRISV	LINC02693	106	A8MQB3
TGPDNSSIDCRLSLA	LENG8	781	Q96PV6
NTQSVGILLEPCSDR	FAM13B	391	Q9NYF5
LPERRGTCADRDNLT	CASP6	61	P55212
NSTPLRAACFDGRLD	FEM1B	121	Q9UK73
SGLSRSRSQPCVLND	FAM53B	261	Q14153
EGQERRSPTTTALCL	PLXNC1	316	O60486
INNLTTPLECGRESR	PDPR	726	Q8NCN5
CGRILPSSGRAEATE	PERCC1	56	A0A1W2PR82
LTNRSARIPCFLAGD	EPX	361	P11678
ARIPCFLAGDTRSTE	EPX	366	P11678
VDTQRFLRPDGTCTL	PRF1	61	P14222
NRSARIPCFLAGDTR	MPO	391	P05164
QLCGSATSLEERPRA	NAV3	1516	Q8IVL0
PGSLETCRRESNPRQ	CWF19L2	341	Q2TBE0
SCLPGVSQLLRRGDE	HES3	71	Q5TGS1
RRQAPSIATIGSTCD	FLNC	2141	Q14315
ARLGRTPAEVVSTCD	GLYR1	311	Q49A26
DRSLLRGPESQSCPS	CYB5RL	56	Q6IPT4
LGVTSLACDDRRPNS	OR56B1	191	Q8NGI3
SRARRVTDAPQGTLC	MYEOV	131	Q96EZ4
LALRDEVPALASCSR	MYCLP1	296	P12525
LCFDSRQRSALPATG	EXPH5	321	Q8NEV8
SEQDSEPGARLTCRI	MED12	1161	Q93074
LQSPCASVRETVLRG	GCN1	1091	Q92616
SLRCSQPEAGRGLSR	MEFV	141	O15553
AERFDTALCVLGTPR	RFPL4A	131	A6NLU0
PSCANVLLRADASLG	PRR25	276	Q96S07
TRRTFLDPQSCGDLL	EPHA10	616	Q5JZY3
APESTLRRLCLGQGA	HAUS5	26	O94927
RLDREELCGTLPSCT	PCDHGC3	91	Q9UN70
PFSTATQRTAGEDCR	GRPEL2	31	Q8TAA5
QPLRQTVSEEGCRSR	GREM2	76	Q9H772
RDTSDTPLCQLSQGI	GPR35	81	Q9HC97
PASNLTSRLSDCVER	KLHL5	666	Q96PQ7
ARGAPLAQELCSESI	KIF18B	561	Q86Y91
LTNCVPGVLDRRDSA	HS6ST1	156	O60243
CQPDATGSSLLRLRD	PPFIBP2	446	Q8ND30
IETELRCASPRSLAG	LRIT1	226	Q9P2V4
CPGESARAASEEVSR	MOCS1	31	Q9NZB8
NDCEVLTTLTPDTGR	PIPSL	541	A2A3N6
TLRCQVEDGSPRTSL	ICAM3	136	P32942
ATARERVTACTPSDG	OPRD1	351	P41143
SLTAARNACRAGTEP	TRIP13	256	Q15645
RNACRAGTEPSDAIR	TRIP13	261	Q15645
RTDDLCLDVSRLNGP	GALNT13	476	Q8IUC8
VQEGSSATFRCRISP	OBSCN	3016	Q5VST9
TPRPSSEACGEAQRL	OBSCN	6971	Q5VST9
DQSGSSSNREPLLRC	NCOA4	6	Q13772
SRIGLSAPSNCISED	PAPPA2	1361	Q9BXP8
ANSPVEDRRGVASCL	PDP2	116	Q9P2J9
GRRLNRECLQPTSAA	BTBD18	136	B2RXH4
STPRLREQDCGEPAS	FZD6	606	O60353
SPRAAEELLQRCISS	APC2	1621	O95996
RSNGERFPDLSCEIL	ADAMTS9	1411	Q9P2N4
EDLRFSCSVRTAGRP	IGSF3	426	O75054
RGLCIERLSASPAQE	ICE1	506	Q9Y2F5
SSCRDPGDKVSILQR	CBLIF	101	P27352
LEEGTLVAANCSTPR	KLRG2	386	A4D1S0
SALGVAPASRNETCL	GPR37	26	O15354
RTLDQQCTVSRPGLA	ATG7	566	O95352
SSTALNRPSVREGAC	C2orf83	111	Q53S99
SARARLASCPESNLG	DACT2	616	Q5SW24
ELPAGSRVELVNTSC	CR2	671	P20023
QLCTRASSSEIPGRL	DNASE2B	211	Q8WZ79
LDTSSRGEQCEPILR	DOCK2	721	Q92608
DLIGESTIRCTSDPQ	CR1	461	P17927
DLIGESTIRCTSDPQ	CR1	911	P17927
NECRPTEFAVRSGLL	GHSR	196	Q92847
EAVSATGQTACPALR	COL20A1	821	Q9P218
RQLNSCLARLGTPEA	CTTNBP2	1316	Q8WZ74
VGESRALCPVESATR	DYTN	166	A2CJ06
SQRVQDRLLAAPGCS	FRMPD3	6	Q5JV73
ASRCLSEEVGSLRPL	GPR32P1	31	Q8NGA4
SRQESSCGSLELQLP	CENPT	121	Q96BT3
DLTIAESNCPRGARV	COL6A3	2431	P12111
VVDELGCSRQRAPSS	ATOH1	136	Q92858
LAEDGEVRSSCRTAP	COL21A1	21	Q96P44
IRDTSQEPCGRLSFL	ANK3	1401	Q12955
GSRVSSGRDLNCVPE	PRMT5	11	O14744
ESRCNPSEAGASLLV	C17orf80	161	Q9BSJ5
SACSSEAPEERSGRR	BTBD7	1076	Q9P203
TNDVCSEPLRGHRTT	LTBP2	1591	Q14767
RDSGRLSPDLSVCGQ	HASPIN	141	Q8TF76
SRALVGQSRRKPCES	MAST3	351	O60307
LCSERLGNSERVSAP	LTBP4	326	Q8N2S1
PLVLDGSQRRCVSNE	LTBP4	1326	Q8N2S1
NGVERVCPESLLQSR	IRAG2	66	Q12912
VQSLDCRLVAEPSGS	IRF9	236	Q00978
GRTACPSLQEATRLI	KNDC1	886	Q76NI1
SPCATREKSRGQREL	CUL9	286	Q8IWT3
SSSRRAPQTGIVDEC	IGF1	81	P05019
RGPAVRALCQITDST	COPG1	121	Q9Y678
SQELPCSSEGSRENL	E4F1	356	Q66K89
QAVCAPSRVSFLTGR	IDS	81	P22304
TTSGAERTAPRRNCL	CELSR3	221	Q9NYQ7
QQGSTIAPRALSTRC	GRIK4	606	Q16099
SLACRRQSIPEEFRG	GRIP2	31	Q9C0E4
DPQELNGITRALCAT	FASN	301	P49327
NGITRALCATRQEPL	FASN	306	P49327
TAGPSCTLLEEAFRR	HEXB	86	P07686
GNSGRLVITPLTDRC	DNAH2	1771	Q9P225
ILQASLSSLCRAGDP	DNAH2	2096	Q9P225
NDCEVLTTLTPDTGR	PSMD4	56	P55036
RSLVESGCPASIVNE	RNF41	231	Q9H4P4
EETTASCGLPCLRQR	SCUBE3	561	Q8IX30
RAEQPLSVGRLCSTI	SLC45A1	536	Q9Y2W3
LGRVAGLCSNIRDSS	POLD1	421	P28340
SRTTAACANVLTPDR	C2CD4A	31	Q8NCU7
IRSDSGDEQLPTICR	CACNA1D	1811	Q01668
IQSILDSRCSVAPGS	FPGT	416	O14772
VTLRLSGNPLTCDCR	LINGO4	351	Q6UY18
QARLAECLRRSSAPA	P2RX6	396	O15547
NCSASRRIRPESLQG	PKD1	2956	P98161
PCSGSLDGRELSRQV	PPEF2	376	O14830
LCGDTSVPASQVRSL	PTPRM	1156	P28827
SNVSLARLTRGLECP	ARHGAP30	436	Q7Z6I6
PEATRVLLSAGCRAD	MIB2	511	Q96AX9
AAPERQEGSSLTLTC	MCAM	351	P43121
ARDPASLTRGLCQAL	GRIN3B	81	O60391
SLSLREGEPFELRCT	PTGFRN	156	Q9P2B2
ECSVRNGSSIVDLSP	IGF2R	1651	P11717
ARPDLAGTCQAELTA	MINDY2	131	Q8NBR6
VLPTEDRSNLNRCGF	PGGT1B	81	P53609
SQVTCTEALLRAPGA	PLD6	46	Q8N2A8
ERLQCPAGSARAALA	RSBN1	16	Q5VWQ0
VSESQCSRSPGRLQE	SYTL3	161	Q4VX76
AERFDTALCVLGTPR	RFPL4AL1	131	F8VTS6
TVAEGPSSCLRRNVI	SOHLH1	46	Q5JUK2
RDCSGPLSALTELNT	BNIP1	31	Q12981
AASTPTQLGRCDRFE	SORL1	1461	Q92673
PVCRKSLNGEDSTRQ	RNF115	266	Q9Y4L5
CPTLLTRDGDRIRSN	SMCHD1	1856	A6NHR9
CPVQLGTLRNDSLEA	TEX14	11	Q8IWB6
CTLVRGDSSPRQAEL	SH3D21	436	A4FU49
IQTRGRSCSSLAPGD	SSPOP	2851	A2VEC9
DALCPQRGSRAPESR	SPATA5L1	306	Q9BVQ7
LERDNTGRCRLSSPV	RNASEH2A	6	O75792
GPASEAALQLLCRAD	RNF187	86	Q5TA31
SLRSRAECDRVSPAS	SYT17	456	Q9BSW7
EAREVAASCRLQGAP	TMEM132B	166	Q14DG7
ALEVASRLSPRAQGC	LRRC56	501	Q8IYG6
AARPALAQCRALSVD	KIFC3	76	Q9BVG8
RNIEGATLTLQSECP	MTF1	116	Q14872
RDFTPVCTTELGRAA	PRDX6	41	P30041
ASLDGRPGDRVNLSC	MPIG6B	21	O95866
FISCDRTGRRNAVPD	PKIG	11	Q9Y2B9
ICLGSPEFTDQGRSR	PLEKHA7	541	Q6IQ23
ESPCLRDSPDRRSGS	SATB2	6	Q9UPW6
RTLSDESLCSGRREP	SIPA1L3	1541	O60292
PTTAFTVLECEGSRR	SHKBP1	541	Q8TBC3
STDAGERARLLQSPC	SLC38A7	16	Q9NVC3
DRGCLSLNLRSPNIS	TEKT2	186	Q9UIF3
CRVRAIGADPSSTLV	MUTYH	241	Q9UIF7
ESENSRPRRSCTLEG	RERE	31	Q9P2R6
CSRPDSGLVFNVLRD	SEMA4D	281	Q92854
LSLNRTPSEIIERGC	SLCO1B7	101	G3V0H7
TVAAVLSRAQGCRSP	STARD9	3046	Q9P2P6
LSRAQGCRSPSAPDV	STARD9	3051	Q9P2P6
ASGRCTLPIDESNTI	NPRL2	141	Q8WTW4
GLRPEAELCAQALAS	SRCAP	2546	Q6ZRS2
IPDCTSRDQLGRQTD	PI4KAP2	386	A4QPH2
LNISPIGRSCTLEER	PMM1	136	Q92871
EGKNCSRDPRAIRVS	PLA2G3	436	Q9NZ20
LSGSPRSCSEQARVF	OSER1	246	Q9NX31
LASCLTPSGAEDLQR	RDH5	56	Q92781
AADSRDCRSPGLLDT	SLX4	1461	Q8IY92
CTLTREDNRSLGVIP	TET1	1686	Q8NFU7
NRRVGLAASNSLCSP	ADAMDEC1	316	O15204
EREGSSLDSPRSKRC	CALCA	71	P01258
CSRETSPNRIGLARS	CLASP1	726	Q7Z460
SVDGRPVRLQLCDTA	RHOU	91	Q7L0Q8
ACGRPDLTDDTQLLS	RNF31	746	Q96EP0
VRRSEPSLSTCQQGE	SLC49A3	401	Q6UXD7
LASQLPGQRLCAEES	ZBTB48	651	P10074
SSLLCARQGAANEPR	TDP1	31	Q9NUW8
QSRERGITLDLGFSC	EEFSEC	41	P57772
TSRQRPGSDECLRVA	SPATA2	31	Q9UM82
SVASCAPQLLGDRRV	ZC3H3	251	Q8IXZ2
AVLSAGDPDPSRCLR	ZFAT	661	Q9P243
SRCLRSNPAEASDLL	ZFAT	671	Q9P243
PQREELASCARTLAL	ZSWIM5	941	Q9P217
DECTQIIARARAPGT	ZBTB45	116	Q96K62
GSQLTPDRCGLRFEE	RORC	221	P51449
AIECSLARIAPSGDQ	TDRKH	416	Q9Y2W6
ARLSVSLCDLNVPGA	NEURL1	246	O76050
ECPRGLQETSDLLSQ	SPATA31A1	86	Q5TZJ5
CPPSRAARESLQELG	RIPOR3	166	Q96MK2
LLQLDGTPRVCRAAS	RIPOR3	826	Q96MK2
RCATSSQPLAARGVA	RAPGEF1	816	Q13905
NSQRLSRGSEESPPC	SLMAP	81	Q14BN4
LGCNITISEDITPRR	STAMBPL1	36	Q96FJ0
ENSLPLGERRTIFNC	THSD1	291	Q9NS62
QGPRSCREAASLVED	ZSCAN1	101	Q8NBB4
SVLTPLRGDVASCNT	ZC3H11A	576	O75152
GDLSTRRLNECISPV	SP100	6	P23497
RGNLRPFICSTDENT	STAP1	261	Q9ULZ2
RDRDPNSLLISCAVS	TNXB	4171	P22105
ASSIPVGSRCEVRAA	TBCB	156	Q99426
RATGTAFRRSPCNLI	TRPV6	186	Q9H1D0
CQGRDLLTEESPSGR	TTC3	1996	P53804
RRRSISCPSCNGLAD	TENM4	1211	Q6N022
PAETTGQARRCDRKS	STAB2	21	Q8WWQ8
CRGTEPTIRSCRLDN	SCART1	196	Q4G0T1
SLCQREGDTVPSFLR	ARHGAP9	546	Q9BRR9
VTELGPSCSQQDLSR	TECPR2	771	O15040
IAELSPGAINSCRSE	TBC1D30	606	Q9Y2I9
SDQLSLGSSRVPRCG	RPAP1	1026	Q9BWH6
PGGSLSERRSVICDI	TCF20	856	Q9UGU0
SECLNNIGDSSPLIR	TNPO1	101	Q92973
SVNCRDIEGRQSTPL	TNKS2	516	Q9H2K2
CRRDSVLEPGLASSP	nan	121	Q8N1X5
QCRVLGTSPEAIDSA	CAD	1031	P27708
LTEGCLRSLSGDLNR	ZNF839	716	A8K0R7
RPSPTARGANCDVEL	TSGA10	11	Q9BZW7
CGKRSLPVDSTQARR	ZNF786	301	Q8N393
EGACPRTATALADRA	TPRN	396	Q4KMQ1
GRKRRQSSDSCSEEP	ZNF687	1076	Q8N1G0
ECEIRNSGSASRSDP	PSG2	216	P11465
SQSRDPRALLGALCQ	TARBP1	11	Q13395
SRPVSCSGRDALLDQ	WASL	426	O00401
RRVKSGLCSQPEESQ	WDR27	261	A2RRH5
GSRSCDRGENPVSLS	nan	76	Q6ZVU0
EAVSCSRLAGAPRGL	MID2	466	Q9UJV3
QRVTLRCSPRSGDLS	TRBV9	36	A0A0B4J1U6
ERCTCDDSPGLESRQ	WNT9B	141	O14905
PGAAEERACQSLASR	GTF3C1	536	Q12789
PAGTRLLSQPCASDR	VWA8	406	A3KMH1
RSRASCFTGLNPTIV	SMC5	876	Q8IY18
AQAALRTELSACGPL	PRSS16	261	Q9NQE7
RTELSACGPLGRAEN	PRSS16	266	Q9NQE7
LARALCSGSPAERRQ	TYMP	356	P19971
PRAVSCLATAQEGAR	ZNF106	1656	Q9H2Y7
PRADTLLGSSGRDCE	SPATA6	266	Q9NWH7
RLPNRQLISCSEDGS	WDR41	331	Q9HAD4
DSVRLALRNDSACNP	ZP4	211	Q12836
CLVRTTDRSPAAEGL	TRIO	1696	O75962
ASGPREALSQLRVLC	ZKSCAN5	61	Q9Y2L8
VRTSQATPCRGLSRE	USP54	1386	Q70EL1
RTGLQVSECSPEQLA	ZAN	2526	Q9Y493
QRPGLVAQCLRDSES	HECTD3	451	Q5T447
TDVSPARDEGSLRLC	KMT2D	1246	O14686
ARDEGSLRLCTDSLP	KMT2D	1251	O14686
DARLGLCARSNDAVP	LRP4	1701	O75096
SIRELGDPAGRSSTC	LIME1	256	Q9H400
VTFPGLSNACSRARD	NAALADL1	691	Q9UQQ1
SVDDDPNTARCLRVG	NEB	4756	P20929